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The Role of Structure in Protein Evolution
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Identifying sites under evolutionary pressure and predicting the effects
of substitutions at those sites are among the greatest standing problems in
bioinformatics and computational biology. Moreover, the two problems have
traditionally been separated by the enormous chasm that exists between molec-
ular evolutionary biologists interested in the evolutionary process and theoret-
ical chemists interested in free energy changes. As a result, identifying sites
under selective pressure has most often left out any semblance of structural bi-
ology and biochemistry; likewise, theoretical chemistry tends to rely strictly on
first principles calculations rather than thinking first about biologically simple
and interpretable results. Here, I have tried to integrate these two intuitions
with regard to protein function and evolution. First, I developed a model that
implements structural measurements into a traditional structure-blind molec-
ular evolutionary model. This structure-aware model performs significantly
better at identifying sites under both purifying and diversifying selection than
vii
its structure-blind counter part. Second, I go further to understand the extent
to which structural features of any kind can predict the evolutionary pro-
cess. By comparing site-wise evolution between human and avian influenza,
I find that structural features can account for 24% to 36% of the evolution-
ary pressure on influenza hemagglutinin. Third, I developed a computational
method based on first principles molecular dynamics simulations to predict
the biological effect of substitutions in the Machupo virus–Human receptor
protein–protein interface. I found that relatively simple energetic proxies of-
fer a reasonable substitute for rigorous free energy calculations; such simple
proxies could allow non-experts to naively implement first principles methods
without being forced to consider all possible degrees of freedom for post hoc
calculations.
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Chapter 1
Introduction
Nearly since the discovery of the function of DNA and the subsequent
push to decode the information it contained, there have been attempts to
understand the evolutionary process through sequence analysis. For the flu,
starting from a very naive place, some early efforts largely focused on specu-
lation about the likely functional result of amino acid substitutions. One such
attempt analyzed the biochemical effect (more hydrophobic to less hydropho-
bic, etc.) of substitutions without regard for their position in the protein
structure [58]. By contrast, several studies focused on the substitution within
the context of the final folded protein. For example, one study compared a
single sequence of hemagglutinin from the 1968 emergent strain of H3N2 in-
fluenza to a small number of subsequent strains, and contrasted amino acid
substitutions that carried the biggest putative biochemical changes (charged
to uncharged, etc.) [105]. Although this method did pay some dividends in
terms of understanding influenza, it provided little information about the evo-
lutionary process of the evolving hemagglutinin protein responding to host
pressure. Moreover, each of these studies was almost completely unsystematic
and very speculative due to technical and methodological limitations.
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More recently, as there has been enormous growth in the number of
available genetic sequences, it has become possible to calculate the degree
to which sites in individual proteins are under evolutionary pressure [107].
Although perhaps not strictly a method from molecular evolution, one common
approach is to use the Shannon information entropy at each site (Si) defined
as,
Si = −
∑
i
Pij lnPij, (1.1)
where j represents each of the 20 possible amino acids and Pij is the frequency
of each amino acid j at position i in the alignment. Calculating site-wise
entropies for every position in an amino acid alignment has several advantages
over speculating about possible functional changes. First, even without an
available protein structure, amino acid substitutions are carried out in the
context of protein structure, and they implicitly retain a significant amount of
structural information in one dimensional sequences. As a result, with only an
amino acid alignment, the Shannon entropy can be applied over a broad range
of circumstances [93]. Second, the quantity of sequence entropy is relatively
easy to understand; a higher number means there is more entropy at a site
and thus there is probably a greater amount of diversifying selection.
On the other hand, sequence entropy calculations have several critical
problems for application in molecular evolution. Simple information entropy
leaves out any notion of an expected difference between two different sites in
a protein; it treats every site with the same distribution of amino acids and
leaves no room for alternative assumptions. If as a result of the underlying
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mutational process, two sites in the same protein have different chances of
acquiring substitutions, that difference is not controlled for within the context
of sequence entropy. In addition, any concept of evolutionary time and thus the
ability to appropriately compare sites with substitutions at different branch
lengths is difficult or impossible.
Probably the most important advancement in the field of molecular
evolution was the ability to identify sites under positive selection while con-
trolling for the underlying mutational process [107]. Because synonymous
changes do not change the amino acid sequence, the chance that they will
have a dramatic effect on fitness is very low [107]. Thus, one can calculate
the rate at which synonymous substitutions accumulate (dS) at each site in
a codon-based alignment. Then, the non-synonymous substitution rate (dN)
can be separately calculated for each site and divided by the synonymous rate
to determine the substitution excess of non-synonymous changes at each site;
that number is referred to as the evolutionary rate ω = dN/dS. Since any site
with ω > 1 has an excess of non-synonymous substitutions relative to synony-
mous substitutions those sites are undergoing positive selection. Furthermore,
the quantity ω is relatively easy to integrate into a codon model that includes
terms to account for other important aspects of the substitution process. For
example, parameters for evolutionary time and the difference between transi-
tion and transversion mutations are both included within the model and can
be estimated simultaneously via maximum likelihood estimation.
Despite the advancement of molecular evolutionary techniques, one
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thing has remained lost from the initial analysis of functional biochemical
differences [66, 89]. That is, proteins are three dimensional objects with a
large amount of internal flexibility, and they exist within a heterogeneous bio-
chemical milieu. They must fold appropriately to carry out any physiological
function at all and they must interface with sometimes dozens of other proteins
to carry on a greater functional role within a cell. As a result, an approach
based strictly on sequence analysis will always fail to capture at least some
aspect of the evolutionary process.
We set out to re-integrate structure into molecular evolution, evalu-
ate the extent to which any structure can constrain evolution, and directly
and systematically probe the effects of substitutions in proteins without the
wild speculation of earlier analyses. To that end, in chapter 2 we develop a
molecular evolutionary model in the image of the previous state of the art. In
lieu of the standard ω calculation, we integrate a metric of three dimensional
structure directly into the model [66]. We find that our new method performs
significantly better than the previous state-of-the-art method. Furthermore,
the new model helps us better control for evolutionary heterogeneity of sites
caused by biophysical differences in a protein site’s local environment [66]. In
chapter 3 we more broadly apply our new model to an important test case in
influenza hemagglutinin. We find that even in a viral system with an enor-
mous amount of positive evolutionary pressure, structure can account for 24%
to 36% of evolutionary rate differences among sites in influenza hemagglu-
tinin [64]. In addition, this number very likely represents the lower limit of
4
structural constraints on protein evolution. A human protein with its rela-
tively low level of positive selection would be expected to have an enormous
amount of evolutionary rate variation explained by structure alone. Moreover,
we find that our structural metric can only account for approximately 10% of
the evolutionary rate variation in hemagglutinin. Thus, more than two-thirds
of the rate variation explained by structure has some other determinant. In
chapter 4, starting with previously identified sites in a viral protein–protein
interface, we apply steered molecular dynamics simulations to compute the
energetic effect of substitutions in the interface between a viral protein and
its host receptor [65]. We find that out of 10 mutants tested, 40% could be
differentiated from the wild type complex based only on maximum force cal-
culations. In addition, we find a very strong agreement between our method
and a much more complicated previously established technique.
This research represents a significant advancement to our earlier un-
derstanding of molecular evolution. We have begun the process of bringing
molecules back in to the study of molecular evolution. Our model allows us to
control for purifying pressure in a way that was not previously possible; our
hope is that further work will uncover the remaining structural determinants
of evolutionary rate variations. A forthcoming paper by Shahmoradi et al. in
the Journal of Molecular Evolution will directly address this question, but will
not itself reveal the final keystone in the search for constraints on the process
of evolution in proteins. In addition, our work using molecular dynamics to
probe the effects of mutations in protein–protein interactions provides a man-
5
ner for novice computational biologists to use advanced ab initio techniques
with relatively little understanding of the underlying mechanics of free en-
ergy methods. Though our initial foray took a large amount of computational
power, further refinement of the steered molecular dynamics approach could
easily reduce the required cost by an order of magnitude or more. Moreover,
such a reduction in cost does not come with the added complexity of choosing
contraints for post hoc calculations.
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Chapter 2
Integrating protein structure and sequence
variation to identify sites under selective
pressure
2.1 Introduction
This work has been previously published in the journal Molecular Bi-
ology and Evolution.1 Many approaches to detect sites under selection aim
to identify sites with evolutionary rate ratio ω = dN/dS significantly larger
than one [70, 95]. Maximum-likelihood models are fit to sequence alignments
and ω values for each site are estimated using either random effects (REL) or
fixed effects (FEL) [51,55,70,109]. Most REL models pre-specify a number of
rate classes and fit the ω values for each class as well as the fraction of sites
belonging to each class [51,70,109]. Rates for individual sites are recovered via
an empirical Bayes approach. Some works have also attempted to determine
the optimal number of rate classes, either via a goodness-of-fit criterion [55] or
by employing a Dirichlet process which fits the number of rate classes as well
as their properties [42,85]. By contrast, FEL models directly fit an individual
1A. G. Meyer and C. O. Wilke. Integrating sequence variation and pro- tein structure to
identify sites under selection. Molecular Biology and Evolution, 30:3644, 2013. C. O. Wilke
helped to design the project and write the manuscript.
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ω value to each site [51], thus allowing for as many different rates as there are
sites in the sequence alignment.
One inherent limitation of all these approaches is that they cannot
provide a baseline expectation for the ω value of a given site. For example,
a site with ω = 0.9 would not be identified as being under positive selection,
yet ω = 0.9 might be unusually high—and possibly indicative of selection for
function—if the baseline expectation for this site in this protein was ω = 0.1.
Likewise, sites with particularly low ω—indicative of negative selection and
likely functional importance—cannot be identified at all without a baseline
expectation.
Here, we develop maximum-likelihood models that can provide a base-
line expectation for ω and can identify sites that deviate from this baseline.
Our method is based on the observation that the evolutionary conservation of
a site is correlated with the site’s relative solvent accessibility (RSA, a measure
of solvent exposure of the focal amino acid in the folded, 3-dimensional protein
structure) [9, 16, 29, 34, 68, 80, 86, 99]. In our models, ω is described by linear
functions of RSA. We use a model-fit criterion to identify the optimal number
of linear functions required to describe all sites in a protein, and for each site
we identify to which linear function it most likely belongs.
For a test case, we apply our method to two viral proteins, influenza
hemagglutinin and neuraminidase. We find that models in which ω is RSA-
dependent always provide a better fit than conventional, RSA-independent
models. Further, we find that the number of different linear functions needed to
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describe these viral proteins is small, on the order of 6-10. In general, most sites
in a protein fall into an RSA-dependent range of ω values that we consider the
baseline expectation. Sites outside the baseline are candidates for functional
selecton. In the case of hemagglutinin, these off-baseline sites are enriched
in sites near the sialic-acid binding region. In the case of neuraminidase, few
sites fall clearly outside the baseline region, with the exception of the well-
known oseltamivir resistance site 274. Our method is easily implemented and
broadly applicable to a wide range of scenarios, as long as a crystal structure
is available for the protein of interest.
2.2 Materials and Methods
2.2.1 Sequence preparation
Sequences were downloaded for hemagglutinin 3 (H3) and neuraminidase
(N1) from the influenza Research Database [90]. We selected human influenza
A sequences including strains isolated from all geographic regions and years.
The full set of H3 and N1 included over 10,000 nucleotide sequences from each
protein. This set was then pared to remove all duplicated sequences. After
processing, 2078 sequences remained for hemagglutinin and 3322 sequences re-
mained for neuraminidase. Next, a protein structure was downloaded from the
protein data bank (PDB) corresponding to each of the two proteins (PDBID:
1RD8 for hemagglutinin; PDBID: 1NN2 for neuraminidase). All nucleotide
sequences were translated and aligned to the amino acid sequence from the
corresponding PDB file, using the MUSCLE sequence alignment tool with de-
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fault settings [28]. After alignment, gaps that were introduced relative to the
sequence in the PDB file were removed, and the amino acids were reverted
to their nucleotide codons. To make the subsequent evolutionary rate fitting
more computationally tractable, we randomly selected 500 of the original pared
sequences to be included in further analysis.
For both alignments of 500 sequences, we generated a phylogenetic tree
with RAxML [91]. We used the GTRCAT substitution approximation avail-
able in RAxML; this approximation was chosen to make computing a phy-
logenetic tree computationally tractable with the large number of sequences
used here. Similarly, the multithreading option was used in the RAxMLHPC
version to speed up the computation.
2.2.2 RSA Determination and Binning
Hemagglutinin and neuraminidase are both functional multimers in so-
lution. We used the crystal symmetry of their X-ray structures to determine
the most likely multimeric form for each protein. The program DSSP version
1.0 [49] was used to calculate the solvent accessibility (SA) per site on both
the monomeric and physiologically relevant multimeric forms, and the abso-
lute accessibility was normalized as described previously [9,98]. The sequence
data was then subdivided into eight evenly-spaced bins according to the RSA
of their sites in the protein structure, as described by Scherrer et al. [86].
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2.2.3 Evolutionary rate determination
We implemented a variant of the Goldman-Yang codon evolution model
(GY94, [35]) in the phylogenetic modeling language HyPhy [53]. The model
we used is an extension of the model proposed by Scherrer et al. [86]. Briefly,
we used the standard GY94 matrix but made the evolutionary-rate ratio
ω = dN/dS, the branch length t, and the transition to transversion ratio κ
linear functions in relative solvent accessibility (RSA). We express their RSA
dependence as:
ω(RSA) = ωa × RSA + ωb , (2.1)
t(RSA) = ta × RSA + tb , (2.2)
κ(RSA) = κa × RSA + κb . (2.3)
Further, ωa and ωb are random effects, drawn from discrete distributions
with a finite set of categories. Specifically, the distribution of ωa is described
by pairs of values (ωka , p
k
a), such that Pr{ωa = ωka} = pka, where k = 1, . . . , Da,
ωka ≥ 0, pka ≥ 0,
∑
k p
k
a = 1. Similarly, the distribution of ωb is described by
pairs of values (ωkb , p
k
b ), where k = 1, . . . , Db. The paramter Da determines
the number of ω-slopes in our model, and the parameter Db determines the
number of ω-intercepts. All other parameters (ta, tb, κa, κb) are fixed effects.
The infinitesimal matrix generator Q for the GY94 model has the usual
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form (for i 6= j)
Qij =

0 if more than one nucleotides changes
pij if synonymous transversion
κpij if synonymous transition
ωpij if nonsynonymous transversion
κωpij if nonsynonymous transition
, (2.4)
where pij is the frequency of codon j, the indices i and j run over all 61 sense
codons, and κ and ω are RSA-dependent, as stated above. The transition
matrix for finite evolutionary time t becomes
P = etQ. (2.5)
Here, the branch length t is also a linear function of RSA. Since t can be
considered equivalent to the synonymous substitution rate, our model does not
assume a single fixed synonymous substitution rate at every site, as is the case
in the conventional GY94 model. Scherrer et al. [86] had previously found that
models with RSA-dependent t and κ fit yeast data better than models with
constant t and κ. We confirmed this observation here for influenza proteins.
2.2.4 Optimum model determination
We chose to implement a random-effects model [109] with indepen-
dent slopes and intercepts. Optimization of fit parameters was performed by
maximum likelihood estimation in HyPhy. All parameters except the codon
frequencies pij were determined by maximum likelihood. Estimated codon fre-
quencies were calculated from the entire sequence alignment using the F3x4
model.
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To identify the overall best-fitting model we used the Akaike Informa-
tion Criterion (AIC) [2, 14]. We fit between zero and five slopes and between
one and five intercepts in all pairwise combinations. We defined the best-fitting
model as the one with the minimum AIC value.
2.2.5 Structural mapping
To assign sites to rate classes, we calculated posterior probabilities us-
ing the empirical Bayes approach [70]. For further analysis, we considered
sites to either evolve at the rate given by the class with the highest posterior
probability, or at an average rate calculated over all classes and weighted by
the posterior probabilities.
For each of the proteins tested, sites were selected that showed a high
ω and a low RSA or, conversely, a low ω and a high RSA. Sites of interest
were mapped back to the original protein structure using the molecular visu-
alization tool PYMOL [87]. For comparison, other predicted or verified sites
were mined from the literature. In cases where the numbering convention used
for the published sites was unclear, we three-dimensionally aligned the protein
structure in the literature with our reference structure, using the PYMOL plu-
gin CEALIGN. After three-dimensional alignment, corresponding sites could
be mapped regardless of the numbering convention used for each protein.
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2.3 Results
2.3.1 General approach
We introduced an RSA dependence to the evolutionary rate ω, the tran-
sition/transversion ratio κ, and the branch length t. RSA was incorporated
by making ω, κ, and t linear functions of RSA. For example, ω with RSA
dependence becomes ω = ωa × RSA + ωb, as described previously [86]. In the
context of random-effect likelihood models, the intercept ωb, the slope ωa, or
both can be either random or fixed effects. Note that Scherrer et al. [86] used
fixed effects for both ωa and ωb. Here we systematically evaluated all possible
combinations of fixed and random effects. We fit models with multiple inter-
cepts and a single slope (ωb is a random effect and ωa is a fixed effect), with
a single intercept and multiple slopes (ωb is a fixed effect and ωa is a random
effect), and with both multiple intercepts and multiple slopes (both ωb and ωa
are random effects). For comparison, we also fit a model with one intercept
and one slope (both ωb and ωa are fixed effects). We treated κ and t as fixed
effects in all models. We represented the traditional, RSA-independent ap-
proach by a random-effects model with multiple intercepts for ω and no slope
for κ, t, or ω. In each case, we identified the optimal number of rate classes
by AIC.
Conventionally, one would use an RSA-independent model to identify
sites with ω > 1. Including an RSA dependence allows us to identify a subset
of sites with ω < 1 that likely experience functional selection (e.g., sites that
experience a combination of purifying and diversifying selection, such that the
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resulting ω value falls below one but is still elevated relative to typical sites at
this RSA). The RSA dependence also allows us to identify sites under partic-
ularly strong negative selection. Figure 2.1 shows a schematic representation
of a typical result from our model. A canonical trapezoidal shape emerges
from the data where we expect the vast majority of sites to be found. This
shape is determined by the structure of the protein, and its exact location and
size will vary among structures. Furthermore, if one performs a Box-Cox [11]
transformation to produce normally distributed y-values, then dN/dS versus
RSA becomes a rectangle with a simple RSA dependence. We consider any
site outside of this region to be important and likely under selection (positive
or negative) for function. As sites with ω > 1 would be found by traditional
analysis, additional sites found by our method are sites with low RSA and
comparatively high ω < 1 and sites with high RSA and very low ω  1.
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Figure 2.1: Regions of interest in ω–RSA plot. Most sites in proteins fall into
a trapezoidal region we consider the neutral baseline. Sites with ω > 1 are
generally considered to be under positive diversifying selection. In addition to
such sites, our method can also identify sites with an ω < 1 but either larger
or smaller than expected given their RSA. These sites fall into the triangular
regions below ω = 1 that are either above or below the neutral baseline. Sites
in these regions experience either an accelerated or a reduced rate of evolution
relative to the baseline and are likely to be functionally important.
Unexpectedly conserved sites are particularly difficult to find by tradi-
tional analysis. Sites with low ω are abundant, because most sites experience
some negative selection pressure solely due to the requirement that the protein
fold properly and be stable. With no baseline expectation for ω at each site, it
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is unclear which of the sites with low ω are particularly important, for example
because they are critical for function. As the majority of conserved sites have
low RSA values, conserved sites with high RSA stand out as unusual. By in-
corporating RSA into models of protein evolution, we can identify sites under
purifying selective pressure that would normally be missed. Similarly, with
our method, sites that have a high RSA and correspondingly high ω (possibly
exceeding 1 by a small amount) can be included in the null hypothesis (the
neutral baseline in Fig. 2.1); such sites might otherwise be considered to be
undergoing positive selection.
2.3.2 Application to influenza hemagglutinin and neuraminidase
We applied our method to the influenza proteins hemagglutinin 3 (H3)
and neuraminidase 1 (N1). We fit a total of 30 different models to each protein;
in these models, the number of intercept classes varied between one and five,
and the number of slope classes varied between zero and five. The models
were compared directly by subtracting the AIC of each model from the global
minimum AIC (corresponding to the best-fitting model). For hemagglutinin,
the model containing three slopes and three intercepts provided the global
minimum AIC (Figure 2.2). For neuraminidase, the global minimum was found
in the model with two slopes and three intercepts (Figure 2.3). Furthermore,
all models with at least one slope (i.e., incorporating RSA) gave a substantially
better fit than those not incorporating RSA. Likelihood values and numbers
of fitted parameters for all models are given in Tables S1 (for hemagglutinin)
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and S2 (for neuraminidase).
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Figure 2.2: Model fit as a function of the number of slopes and intercepts in
the model, for the influenza haemagglutinin trimer. The shading reflects the
difference in AIC between the best model (3 slopes and 3 intercepts in this
case) and all other models.
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Figure 2.3: Model fit as a function of the number of slopes and intercepts in
the model, for the influenza neuraminidase tetramer. The shading reflects the
difference in AIC between the best model (2 slopes and 3 intercepts in this
case) and all other models.
Hemagglutinin forms a homo-trimer on the surface of quiescent in-
fluenza virus, and neuraminidase is only enzymatically active as a homo-
multimer (tetramer) within infected cells. Therefore, for both proteins it is
not clear whether RSA measurements should be performed on the monomeric
or the multimeric forms. It seems likely that both the monomeric and mul-
timeric forms will have some influence on sequence evolution. For example,
the monomeric form of a protein should evolve to prevent unfavorable homo-
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multimerization. By contrast, the multimer must evolve to form a stable qua-
ternary structure. Both the monomeric and multimeric forms will evolve to
prevent aggregation, but they may do so on different surfaces. Further compli-
cating matters, even for proteins that function only as multimers we generally
have no information about the fraction of time they spend as multimers. If,
in solution, the proteins spend very little time multimerized, evolution due to
biophysical constraints will act more often on the monomeric forms. We cal-
culated RSA values on both the monomeric and the multimeric forms for both
hemagglutinin and neuraminidase. For both proteins, the multimeric form
provided a better fit than the monomeric form for every combination of slopes
and intercepts (not shown). Therefore, we considered only the multimeric
forms of these proteins for further analysis.
After fitting the models, we assigned individual evolutionary rates to
each site. We employed the empirical Bayes approach to calculate posterior
probabilities for each site to belong to each rate class. We then considered two
alternatives of how to convert rate classes into site-specific rates. First, we
assigned sites to their most probable slope and intercept and then calculated
evolutionary rates given each site’s RSA. Second, we calculated an average
rate by weighting each rate class with the probability that a site falls into that
class. To calculate the weighted average ωave, we write
ωave =
∑
i,j
ppij(ω
i
a × RSA + ωjb) , (2.6)
where ωia is the slope in category i, ω
j
b is the intercept in category j, and ppij
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is the posterior probability of slope i and intercept j at the site of interest.
Figure 2.4 shows results for hemagglutin obtained under the first ap-
proach. We selected four representative cases. The top left graph represents
the traditional, RSA-independent case. The top right and bottom left graphs
represent the mixed models with a single slope and multiple intercepts and
with multiple slopes and a single intercept, respectively. The bottom right
represents the overall best-fitting model, with ∆AIC = 0. Figure 2.5 shows
the same four cases with rates calculated under the averaging scheme. In com-
parison to Figure 2.4, averaging reduces some of the very high ω values. Note
also that ωave values are less sensitive to the exact model specification. For
the four models shown in Figure 2.5, the ωave values for the best model corre-
late with the ωave values for the other three models with Spearman ρ = 0.91,
ρ = 0.94, and ρ = 0.91, respectively (in order top left, top right, bottom left).
All correlations are highly significant.
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Figure 2.4: Assignments of sites to rate classes, for the influenza haemagglu-
tinin trimer. Each graph shows each site’s dN/dS plotted against the site’s
RSA. Sites are assumed to evolve at a dN/dS determined by the rate class
they are most likely to fall into. Top left: The best model with multiple in-
tercepts and no slope (no RSA dependence). Top right: The best model with
multiple intercepts and one slope. Bottom left: The best model with multiple
slopes and a single intercept. Bottom right: The overall best model, with three
intercepts and three slopes. ∆AIC values are calculated relative to the overall
best model. Figure 2.5 shows the same results but averaged over rate classes.
By fitting an RSA-dependent model to hemagglutinin data, we could
identify sites with high ω that may not experience accelerated evolution. The
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RSA-independent model (Figure 2.5, top left) showed that there are a number
of sites with ω > 1. By incorporating RSA, we were able to filter out those sites
with high ω that had correspondingly high RSA. For hemagglutinin, the best-
fitting model suggested that at least one site with elevated evolutionary rate
should be considered part of the neutral baseline (Figure 2.6). We also found
a set of very exposed sites that were highly conserved. In total, for hemagglu-
tinin we found 33 sites that we predicted to experience accelerated evolution
(above the upper dashed line in Figure 2.6) and 9 sites that we predicted to
be exceptionally conserved (below the lower dashed line in Figure 2.6). These
sites are listed in Table S3.
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Figure 2.5: Assignments of sites to evolutionary rates, for the influenza
haemagglutinin trimer. Each graph shows each site’s weighted average dN/dS
plotted against the site’s RSA. Top left: The best model with multiple inter-
cepts and no slope (no RSA dependence). Top right: The best model with
multiple intercepts and one slope. Bottom left: The best model with multiple
slopes and a single intercept. Bottom right: The overall best model, with three
intercepts and three slopes. ∆AIC values are calculated relative to the overall
best model.
Hemagglutinin is an important target for protective immunity and has
therefore been the topic of many previous analyses. It is well known that
many sites in human-influenza hemagglutinin experience adaptive evolution,
24
in particular in domain 1 of the protein, which contains the sialic-acid binding
site [8]. Here, we asked whether sites in the sialic-acid binding region were
enriched in sites experiencing accelerated evolution. The sialic-acid binding
site is expected to be under positive selection, as it is a major target for host
range shifts and antibody binding [103]. We identified all sites within 8A˚ of
sialic acid in the hemagglutinin structure, and analyzed where they fell in the
ωave–RSA plot. We found 39 such sites. (Note that we do not expect all of these
sites to have high ω, and neither do we expect all sites with high ω to be near
the sialic acid binding region.) Of these 39 sites, 10 fell above the dashed line
in Figure 2.6 and 29 below. This represents a significant positive enrichment
of such sites at high ω (Fisher’s exact test, OR = 6.6, p = 6.1× 10−5).
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Figure 2.6: Average ω versus RSA for hemagglutinin, obtained from the opti-
mal model (3 slopes and 3 intercepts). Dashed lines indicate the trapezoidally
shaped neutral baseline (as ascertained by eye). Sites highlighted in red are
within 8A˚ of the sialic-acid binding region. Sites above the upper dashed line
are significantly enriched in sites near the sialic-acid binding region (Fisher’s
exact test, OR = 6.6, p = 6.1× 10−5).
We visualized all sites evolving at either accelerated or reduced ω by
mapping them onto the hemagglutinin structure (Figure 2.7). We found that
the majority of the sites with accelerated ω fell near the top of the hemagglu-
tinin structure, but others occurred in small clusters throughout the structure
(Figure 2.7A). The clustering of these remaining sites suggests that their evo-
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lutionary rate is driven by selection pressure mediated by antibody binding.
The sites with unusually low ω given their RSA fell into three categories. Three
sites (69, 121, 141) were relatively close to the sialic-acid binding region (Fig-
ure 2.7B, C), even though not within the 8A˚ we used as cutoff to identify sites
near the sialic-acid binding region. (Their distances to the sialic-acid binding
region were 17A˚, 18A˚, and 12A˚, respectively). These sites may provide cru-
cial structural support for proper functioning of the hemagglutinin protein.
Three more (163, 236, 238) seemed to be involved in the trimer interface (Fig-
ure 2.7B, C). The remaining sites were located throughout the protein, and
their possible function was not readily apparent (Figure 2.7A).
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Figure 2.7: Sites of interest identified for hemagglutinin. Sites that fall above
the upper dashed line in Fig. 2.6 are colored orange. Sites that fall below the
lower dashed line in Fig. 2.6 are colored light blue. The polypeptide backbone
is colored green. Sialic acid is represented by the space filling model near the
top of the molecule. (A) View of the entire hemagglutinin monomer. (B) View
of the sialic-acid binding region. Sites that are highlighted as “SA binding?”
are unusually conserved and close to (though not within 8A˚ of) the sialic
acid. Sites that are highlighted as “trimer interface” are unusually conserved
and seem to be important for trimerization. (C) View of the trimer-interface
region. Labeling of sites is as in part (B).
We next considered neuraminidase. Overall, neuraminidase showed
substantially lower ω values than hemagglutinin. While hemagglutinin had
many sites with ω > 1, neuraminidase had just a few. The model with mul-
tiple intercepts and no slopes placed five sites at ω > 1 (Figures 2.8 and 2.9,
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top left). No individual site seemed to stand out particularly under the RSA-
independent approach. By contrast, under our best model for neuraminidase,
with 2 slopes and 3 intercepts, one site stood out as having low RSA and par-
ticularly high ω (Figures 2.8 and 2.9, bottom right). This site is position 274;
a common oseltamivir resistance mutation occurs at this site (most commonly
H274Y). For neuraminidase, we did not find any highly exposed sites that were
particularly conserved. In total, for neuraminidase we found 9 sites that we
predicted to experience accelerated evolution (Table S3).
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Figure 2.8: Assignments of sites to rate classes, for the influenza neuraminidase
tetramer. Each graph shows each site’s dN/dS plotted against the site’s RSA.
Sites are assumed to evolve at a dN/dS determined by the rate class they are
most likely to fall into. Top left: The best model with multiple intercepts
and no slope (no RSA dependence). Top right: The best model with multiple
intercepts and one slope. Bottom left: The best model with multiple slopes
and a single intercept. Bottom right: The overall best model, with three
intercepts and two slopes. ∆AIC values are calculated relative to the overall
best model.
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Figure 2.9: Assignments of sites to rate classes, for the influenza neuraminidase
tetramer. Each graph shows each site’s weighted average dN/dS plotted
against the site’s RSA. Top left: The best model with multiple intercepts
and no slope (no RSA dependence). Top right: The best model with multiple
intercepts and one slope. Bottom left: The best model with multiple slopes
and a single intercept. Bottom right: The overall best model, with three inter-
cepts and two slopes. ∆AIC values are calculated relative to the overall best
model.
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2.3.3 Comparison of identified sites with prior work
The positively sites we found here were broadly in agreement with
previously identified sites. In a seminal paper, [15] used positively selected
sites in H3 to predict influenza evolution. Of the 18 sites they found, 11 sites
fell above our null expectation (Figure 2.10, left). More recently, [56] identified
24 sites under directional selection in hemagglutinin; we identified 11 of those
24 sites (Figure 2.10, right). Both studies also identified a few sites that had
a very low ω in our analysis. Some of the differences between our and their
results are likely due to differences in the sequences analyzed.
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Figure 2.10: Comparison of our results with previous work on hemagglutinin.
The left graph highlights sites found by [15] to be under positive selection.
The right graph highlights sites found by [56] to be under directional selec-
tion. Dashed lines indicate the putative region of the structurally constrained
neutral baseline.
Neuraminidase is the protein responsible for enzymatic cleavage of sialic
acid following viral entry. In comparison to hemagglutinin, neuraminidase is
a less commonly studied protein due, in part, to its intracellular function. As
32
neuraminidase is never exposed to the periplasm, it is not likely to be a major
target of protective immune responses. Therefore, we do not expect many of
the sites in neuraminidase to evolve very rapidly. Indeed, most of its sites
show very high conservation; as mentioned previously, neuraminidase contains
very few sites with ω > 1 (Figures 2.8 and 2.9).
Of those sites found previously by [10], we found only the oseltamivir
resistance site (site 274 in the PDB structure 1NN2, site 275 in [57]) to be un-
der positive selection (Figure 2.11, left). Those Bloom sites conferring epistatic
stability to the resistance mutation were generally elevated relative to a regres-
sion line, but they did not fall significantly above of the baseline expectation.
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Figure 2.11: Comparison of our results with previous work on neuraminidase.
Left: Sites found by [10] to be involved in the evolution of oseltamivir resistance
are highlighted in red. Right: Site 274 and sites found by [57] to have 274 as
trailing site are highlighted in red.
We also compared our results to recent work by [57] (Figure 2.11, right).
They identified sites in neuraminidase that enabled subsequent substitutions
at other sites. We specifically considered sites that they identified as leading to
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substitutions at the oseltamivir resistance site. Among these sites were half of
the sites identified by [10], so these two studies give highly congruent results.
We found two sites from [57] significantly above the baseline expectation. Our
sites congruent with [57] are 220 and 430 (in PDB structure 2HU0), both near
the sialic-acid-cleaving active site. The remaining sites from [57] were also
generally elevated, but did not rise above the baseline expectation.
2.4 Discussion
We have described a new method for identifying important sites in
protein-coding sequences. Furthermore, we have shown that this new method
fits molecular sequence data better than a conventional random-effects likeli-
hood (REL) approach. To generate improved models, we used the correlation
between RSA and evolutionary rate [29] to define a new, more accurate evo-
lutionary null expectation. We applied our method to two influenza proteins,
hemagglutinin 3 and neuraminidase 1; we classified sites with ω greater than
expected given their RSA as positively selected, and sites with ω lower than
expected as negatively selected. Sites found by our method are in agreement
with experimentally validated sites and with results from other computational
studies. Our method goes beyond previous approaches by finding sites that
would previously have been missed (reducing Type II errors) and by including
some sites in the null that would normally have been rejected (reducing Type
I errors).
Several approaches to fitting evolutionary rate have been developed
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and improved in the last two decades [35,51,52,55,69,70,85,95,107,109]. One
approach, fixed-effect-likelihood (FEL) based fitting [51], involves estimating
an independent ω value at each site; although a FEL approach limits Type I
errors, it can lead to model over-parameterization as there is no obvious way
to penalize over-parameterized models. Another approach, counting methods
[51], is conceptually simpler but estimates independent κ and t parameters at
each site. While ω may vary substantially among sites, κ and t are not likely
to do so; therefore, estimating them per site leads to overfitting. Moreover,
as sites are treated independently, both FEL and counting methods require a
large number of sequences per gene to gain power [51]. Traditional REL-based
rate estimation relies on a predefined distribution for ω and a pre-specified
number of rate classes [51]. As a result, all sites are aggregated to increase
power when a large number of sequences are not available; however, with a
very small number of sequences, REL methods tend to lead to increased Type
I errors [51]. In addition, estimating the number of rate classes becomes a
potential complicating factor for REL methods: Even though a model with k
classes is nested into a model with k+ 1 classes, one cannot simple carry out a
likelihood ratio test to determine which model provides the better fit, because
the nesting is not identifiable [3].
Here, we chose to identify the optimal number of classes by testing all
plausible candidate REL models and ranking them according to their AIC.
We found that the total number of classes needed was relatively small: two
to three slopes and three intercepts were sufficient to describe relatively large
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alignments of hemagglutinin and neuraminidase. In general, the number of
classes for optimal fit will likely vary amongst proteins. Alternative methods
of identifying the optimal number of rate classes include adding classes until a
goodness-of-fit criterion fails [55] or using a Dirichlet process to fit number of
classes as a parameter in the model [42, 85]. Either of these approaches could
be employed with our RSA-dependent model of codon evolution.
When using a random-effects model, one has to decide how to assign ω
values to individual sites. We considered two alternative approaches. To each
site we assigned either the ω value corresponding to the most probable rate
class for the site or an average ω value calculated as a weighted average over
all classes. We think that both approaches are valuable. The first approach
produces simpler graphs, as it highlights the linear RSA dependency employed
in the model. Using this approach, we can easily tell which sites fall into
common rate classes (i.e., are part of the neutral baseline) and which sites
have unusual ω given their RSA. A downside of this approach is that sites
which have comparable posterior probabilities for two or more classes will
appear to belong exclusively to a single class. This downside is alleviated by
the second approach, which will place those sites at intermediate, averaged ω
values. A second advantage of the averaging approach is that average ω values
are relatively insensitive to the model specification (exact number of slopes
and intercepts).
We analyzed a Goldman-Yang model [35] in which both the evolutionary-
rate ratio ω and time t were RSA-dependent, but only ω was implemented
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as a random effect that could vary among sites independently of RSA. An
alternative model would be a structure-aware Muse-Gaut model [69]. The
Muse-Gaut model uses parameters α and β instead of ω and t, with α = t and
β = ωt. In models that incorporate site variability but no structural infor-
mation, the Muse-Gaut model is generally preferred over the Goldman-Yang
model [25,52,55], because the Muse-Gaut model naturally allows for variation
in both synonymous and non-synonymous evolutionary rates (by treating both
α and β as random effects). By contrast, when RSA is taken into account but
other site variation is ignored, the Goldman-Yang model performs better than
the Muse-Gaut model, indicating that ω varies linearly with RSA and β does
not [86]. Whether the Muse-Gaut or the Goldman-Yang formulation should
be preferred in the most general case, incorporating both structural informa-
tion and synonymous and non-synonymous rate variation, remains an open
question for future research.
We have shown that accounting for biophysical constraints in models
of sequence evolution can reduce the frequency of Type I errors, by excluding
sites with ω ∼ 1 at high RSA. For hemagglutinin, we were able to exclude at
least one site with high evolutionary rate that had proportionately high RSA
values. Our model likely also reduces Type II errors, by identifying sites with
ω < 1 as experiencing accelerated evolution. Several of the sites identified
by [15] or [56] (Figure 2.10), or of the sites near the sialic-acid binding region
(Figure 2.6), fell into this category. One drawback of our method is that
defining which sites fall into the null expectation and which fall outside it
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lies ultimately with the human researcher carrying out the analysis. Since
our method is fundamentally prospective, geared towards identifying sites of
potential interest in further experimental analysis, we do not consider this
drawback as particularly severe. It is also important to keep in mind that sites
with ω above the baseline but below 1 could either be subject to a mixture
of positive and negative selection pressures or they could simply be subject
to very little selection pressure at all, despite of their location in the protein.
Finally, we saw some discrepancies between the sites we identified and sites
found in previous works (Figure 2.10). We have no reason to believe that the
inclusion of RSA into our model caused these discrepancies, since they also
arose in our RSA-independent model. Most likely, these discrepancies were
caused by differences in the alignments analyzed.
Several previous papers have proposed models of coding-sequence evo-
lution that incorporate structural information. The simplest approach is to
partition coding sequences according to a structural property (e.g., partition
all sites into buried and exposed sites) and fit a fixed-effects model whose
model parameters may vary by partition [6, 21, 86, 108]. These partitioned
models tend to fit sequence data better than non-partitioned models. They
are good at identifying differences among partitions, but they cannot identify
individual sites that show unusual rates given their partition. More sophis-
ticated models contain selection terms incorporating solvent accessibility or
energetic interactions among residues in a structure [20,81–84]. These models
also tend to fit sequence data better than comparable models without struc-
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tural information. However, it is not clear whether they can be used in a
straightforward manner to identify individual sites under selection. The ad-
vantage of our method is that it is straightforward to implement, it requires
only moderate amounts of processing time, and it produces results that are
easily interpretable. A limitation of all these methods, including ours, with
respect to viral evolution is that they assume site independence, when sites
in most viral proteins are actually tightly linked. This limitation may cause
overinflated variability in evolutionary rates or even biased estimates. The
exact consequences of this limitation have received little attention and remain
poorly understood, however.
One complicating factor in our approach comes from the proper mea-
surement and interpretation of physiologically relevant protein structures. We
tested both the monomeric and multimeric form of each protein, and found
that the multimeric forms produced a better model fit in both cases. It is un-
clear whether the multimeric RSA would always be preferred. Goodness-of-fit
may be related to the most common state of free, solvated protein. RSA values
may also be incorrect because crystal structures reflect a single protein confor-
mation but solvated proteins fluctuate among neighboring conformations. In
future work, one could attempt to improve the accuracy of RSA calculations
by estimating these fluctuations using molecular dynamics simulations.
Even though we introduced RSA dependence into the rate parameters
of our model (ω, t, κ), we held the equilibrium codon frequencies pii constant
throughout all sites in the protein. Holding codon frequencies constant is a
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convenient approximation that is usually employed when calculating evolu-
tionary rates. However, in the structural context, it would be desirable to
make codon frequencies depend on structure as well. Amino-acid frequencies
vary with RSA, the most hydrophobic amino acids being the most common
at low RSA values and the most hydrophilic ones being the most common at
high RSA values [76,80]. Consequently, codon frequencies must similarly vary
with RSA. We suspect that some of this variation was absorbed into κ and
t in our model. Nevertheless, a more realistic model would be desirable. At
present, however, we are not sure how to formulate such a model. We could
make the pii linear functions of RSA as well, but this modeling choice would
add a large number of parameters and possibly lead to an over-parametrized
model.
In summary, our work has shown that accounting for RSA in evolutionary-
rate models improves model fit. In addition, we were able to find the best-
fitting model by exhaustively testing different numbers of slopes and intecepts.
We could confirm extensive selection pressure near the sialic-acid binding site
in the influenza protein hemagglutinin. Further, we could show that the
oseltamivir-resistance site 274 in influenza neuraminidase stands out among
the sites in this protein as experiencing particularly strong positive selection.
Finally, our analysis of hemagglutin and neuraminidase offers new, potentially
important sites for experimental investigation.
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Chapter 3
Cross species correlation of evolutionary rate
variation
3.1 Introduction
This work was previously published in the journal Philosophical Trans-
actions of the Royal Society B.1 Viral proteins are highly variable at the se-
quence level; they accumulate amino-acid substitutions at a rapid pace [27,77].
Yet their structures tend to be fairly conserved. Highly variable surface regions
notwithstanding, most viral proteins need to maintain a specific structure to
carry out their function in the viral life cycle (see e.g. [110]). The generally
accepted picture is that sites in the protein core maintain the overall protein
structure and are therefore most conserved. Sites on the surface are less critical
to the protein structure and hence more free to vary, for example in response
to selection pressures imposed by immune response. This view is based on
the finding, replicated in widely differing organisms and using many different
techniques, that on average sequence variability increases the closer a site is
located towards the surface of a protein [9,16,20,24,29,34,36,68,86,97]. More
1A. G. Meyer, E. T. Dawson, and C. O. Wilke. Cross-species comparison of site-specific
evolutionary-rate variation in influenza hemagglutinin. Philosophical Transactions of the
Royal Society B, 368:1614, 2013. C. O. Wilke helped to design the project and write the
manuscript.
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specifically, in influenza, exposed sites in hemagglutinin and neuraminidase
have been found to evolve faster than buried sites in these proteins [8, 66].
Thus, prior work has clearly established that protein structure influ-
ences site variability. What is less clear, however, is the magnitude of this
effect. Is knowing a site is buried sufficient to predict that the site will be
evolutionarily conserved, or are other factors stronger driving forces for site-
specific evolutionary rates? And similarly, will homologous sites in related but
distinct viral strains evolve at similar rates, or do the nature of the viral strain
and the infected host organism impose stronger influences on site-specific evo-
lutionary rates than the location of a site in the protein structure?
In this chapter, we address these questions for influenza hemagglutinin
(HA). We compare per-site sequence evolution for two different host species
(human and avian) and three HA subtypes (H1, H3, H5), and ask the following
questions: (1) To what extent is rate variation determined by the location of
a site in the structure, as measured by the sites’ relative solvent accessibility?
(2) To what extent is rate variation conserved within HA subtypes among
viruses infecting different host species? (3) Are ω = dN/dS ratios elevated
near the active site (the sialic-acid binding region) of HA? We find that protein
structure, HA subtype, and host biology all affect rate variation in influenza
HA.
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3.2 Materials and Methods
3.2.1 Sequence preparation
We obtained sequences for hemagglutinin (HA) subtypes H1, H3, and
H5 for human and avian hosts from the Influenza Research Database [90]. Us-
ing the built-in curating tools of the database, we carefully selected subsets of
sequences that corresponded as much as possible to well-defined and distinct
viral populations. Sequences were curated within each host species depend-
ing on its subtype. In particular, for each combination of HA subtype and
host species, we considered only sequences that could be linked to a specific
neuraminidase subtype.
Human H1 sequences were obtained from H1N1 strains isolated between
1977 (after the Fort Dix outbreak) until 2008 (before the 2009 flu pandemic).
H1N1 strains since 2009 are not direct descendants of H1N1 strains before 2009
and thus were excluded. We found 2057 distinct H1 sequences. Human H3
sequences were obtained from H3N2 strains isolated between 1968 until 2012.
We found 8315 distinct sequences. Human H5 sequences were obtained from
H5N1 sequences without date restriction. We found 297 distinct sequences.
Avian sequences were curated by subtype with no restrictions placed on
the date range; full data sets from FluDB of H1N1, H3N2, and H5N1 sequences
were used. We found 106, 115, and 2684 distinct sequences, respectively.
In general, the process outlined in subsection 2.2.1 was used here. To
align sequences and map them to the hemagglutinin structure, we downloaded
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a reference structure from the protein data bank (PDB). We used the struc-
ture with PDB identifier 1rd8, which is a structure of the H1 subtype [92].
All nucleotide sequences were translated into amino-acid sequences. Each dis-
tinct set of sequences (human H1, human H3, and so on) was then aligned
to the reference amino-acid sequence from the PDB file, using the MUSCLE
sequence-alignment tool with default settings [28]. For alignments that con-
tained more than 200 sequences, we selected a random subset of 200 sequences
for further analysis. This reduction in alignment sizes was necessary because
maximum-likelihood fitting of codon-evolution models becomes prohibitively
slow for much larger alignments. In addition, phylogenetic trees were built
just as in subection 2.2.1.
To assess the phylogenetic relationship between human and avian align-
ments, we also constructed combined human/avian alignments for H1, H3, H5
and reconstructed trees for the combined alignments. For H1, we found nearly
complete phylogenetic separation between human and avian sequences. All
but three avian and all but two human sequences formed a separate clade
each. The remaining five sequences (introduced from classic swine lineage)
were closer to each other than to either of the two clades. For H3, human and
avian sequences were mostly separated. However, 14 avian sequences fell into
the human clade (12 of those avian sequences grouped together as a single
clade, introduced from the triple-reassortant H3N2 swine lineage). For H5,
we found no phylogenetic separation. Human and avian sequences grouped
together throughout the entire phylogeny. Human and avian H5 viruses are
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not distinct lineages because human H5 is not transmitted effectively from
human to human. All phylogenetic trees are provided as part of the online
supplementary materials.
We calculated relative solvent accessibility (RSA) as described [66] and
in model development. In brief, solvent accessibilities (SAs) were calculated
with the program DSSP [49] and then normalized [9]. The sequence data was
then subdivided into eight evenly-spaced bins according to the RSA of their
sites in the protein structure, as described [86].
3.2.2 Evolutionary rate determination
We calculated site-specific evolutionary rates using two approaches that
integrate sequence data and protein structure, a random-effects likelihood
(REL) and a fixed-effects likelihood (FEL) approach. Both approaches were
implemented in the phylogenetic modeling language HyPhy [53], and our Hy-
Phy scripts are provided as part of the supplementary materials.
The REL approach was previously described [66]. In addition, the
technique was described previously in subsections 2.2.3 and 2.2.4.
Site-specific evolutionary rates were calculated by first calculating pos-
terior probabilities for each site and rate category, using the empirical Bayes
approach [70], and then averaging over all rate categories at each site, as de-
scribed [66].
The FEL model is built on top of the REL model, and can be con-
sidered a structure-aware modification of existing FEL approaches [51]. After
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determining the best-fitting REL model, we re-fit a GY94 model separately
at each site. In this fit, the variables κ and t are not re-fitted to the data but
instead set at each site to the values predicted from the REL model. Thus,
the FEL approach fits only a single parameter for each site, the evolutionary
rate ratio ω.
All data files and analysis scripts are provided as online supplementary
materials.
3.3 Results
3.3.1 Estimating site-specific evolutionary rates in a structural con-
text
We constructed separate sequence alignments for human and avian
H1, human and avian H3, and human and avian H5 (six separate align-
ments; see Methods for a detailed description). We then calculated site-specific
evolutionary-rate ratios ω = dN/dS for each alignment. We carried out these
calculations in a structure-aware framework; our goal was to determine the rel-
ative importance of protein structure and other factors for evolutionary-rate
variation among sites.
There are two alternative approaches to calculating per-site evolution-
ary rates, the random-effects likelihood (REL) method and the fixed-effects
likelihood (FEL) method. Under the REL method, a finite set of ω categories is
fit jointly to all sites in the alignment. Sites are then probabilistically assigned
to categories using an empirical Bayes approach [70, 109]. To obtain distinct
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ω values for each site, we calculate averages over all ω categories, weighted
by each site’s posterior probability to belong to each category [66]. Under
the FEL method, a distinct ω value is fit separately to each codon column
in the alignment. Existing REL and FEL methods tend to have comparable
performance, with either one being preferable in certain applications [51].
We recently introduced a structure-aware REL model, which calculates
ω taking into account the relative solvent accessibility (RSA) of individual
residues. RSA is a measure of how close to the surface a residue is located
in the folded, 3-dimensional protein structure. A residue with an RSA of 0
is located entirely inside the protein structure; it has no contact with water.
A residue with an RSA of 1, on the other hand, is completely exposed. Such
residues tend to occur in variable surface loops. Intermediate RSA values
correspond to partially buried residues.
In the structurally-aware REL model, ω is written as a linear function
of relative solvent accessibility (RSA), ω = ωa × RSA + ωb, and both ωa and
ωb are random variables drawn from discrete distributions with a fixed set
of categories (see [66] and Methods). The optimal number of slope (ωa) and
intercept (ωb) categories is determined by minimizing the AIC. This model
generally produces a better fit than a comparable model without a structural
component. Typical numbers of categories needed for both slopes and inter-
cepts fall between two and four [66].
We fit this model to all six HA alignments, and found that the RSA
dependence was significant in all cases except one (human H5). The optimal
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number of slopes and intercepts varied by alignment (Table 3.1). We also
compared ω estimates predicted by the best REL model with RSA dependence
to those predicted by the best REL model without RSA dependence, and found
that estimates were generally very similar, with correlation coefficients above
0.9 (Table 3.1). We would like to emphasize, however, that this similarity only
arose when we averaged ω over rate categories, as described [66]. Thus, even
though using a model with RSA dependence is preferable in terms of model
fit, a model without RSA dependence can perform almost as well, as long as
ω is averaged over rate categories.
Table 3.1: Comparison of RSA-dependent and RSA-independent model fits.
slopes, intercepts
host HA type best overalla best no-RSAb best RSAc corrd
human H1 3, 2 0, 3 3, 2 0.95
human H3 2, 3 0, 3 2, 3 0.98
human H5 0, 3 0, 3 2, 3 0.99
avian H1 2, 3 0, 4 2, 3 0.92
avian H3 2, 2 0, 3 2, 2 0.97
avian H5 4, 3 0, 4 4, 3 0.96
aNumber of slopes and intercepts for the overall best fitting model.
bNumber of slopes and intercepts for the best fitting model without RSA
dependence.
cNumber of slopes and intercepts for the best fitting model with RSA
dependence.
dCorrelation of logω between the best model with and without RSA. All
correlations are highly significant (p < 10−10).
Next we assessed the reliability of per-site ω ratios, by comparing REL
estimates to FEL estimates. Such a comparison has not previously been done
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for the structure-aware REL model. We implemented a structure-aware FEL
model (Methods), fitted it to all alignments, and found that REL and FEL
estimates were generally very similar (Fig. 3.1). Correlation coefficients were
typically above 0.9. FEL tended to produce slightly higher ω estimates for
large ω values and slightly lower estimates for low ω values. This finding is
consistent with the prior observation of shrinkage in REL estimates relative to
FEL estimates [51]. One downside of the REL approach is excessive shrinkage
if the alignment in small. This problem does not arise in the FEL approach.
By contrast, in the FEL approach the number of sequences in the alignment
imposes a lower limit on the smallest ω values that can be estimated. All
estimates below this limit are simply zero. The REL method, by contrast, as-
signs rates to these sites based on the density of sites with no non-synonymous
variation relative to the density of sites with some non-synonymous variation.
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Figure 3.1: Comparison of per-site evolutionary-rate ratios ω = dN/dS cal-
culated using the REL and the FEL methods. Each dot represents the ω
estimate for a single site. Rugs along the x axis indicate sites for which the
REL method estimated a positive ω but the FEL method estimated ω = 0.
Overall, both methods yield comparable results. Correlation coefficients r are
Pearson correlations, calculated for logω excluding sites with ω = 0. FEL
tends to estimate slightly higher values for sites with high ω and slightly lower
values for sites with low ω. (Significance levels: ∗∗∗p < 10−10.)
Because the REL and FEL methods provide comparable estimates and
REL provides a positive ω for all sites, we used REL for the remainder of
this paper. All results remained qualitatively unchanged when analyses were
carried out using the FEL method.
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3.3.2 Elevated ω near the sialic-acid binding region
When plotting per-site ω against RSA, we found that ω generally in-
creased with RSA, as expected (Fig. 3.2). However, the rate variation around
this overall trend was large. ω varied over one to two orders of magnitude at
all RSA values. We found the least rate variation in human and avian H1, and
the most variation in human H5.
5e−03
5e−02
5e−01
5e+00
OR = 2.5, p = 0.011
0.0 0.5 1.0
RSA
H
um
an
 H
1 
dN
/d
S
5e−03
5e−02
5e−01
5e+00
OR = 3.1, p = 0.0012
0.0 0.5 1.0
RSA
H
um
an
 H
3 
dN
/d
S
5e−03
5e−02
5e−01
5e+00
OR = 3.3, p = 5.2e−04
0.0 0.5 1.0
RSA
H
um
an
 H
5 
dN
/d
S
5e−03
5e−02
5e−01
5e+00
OR = 2.9, p = 3e−03
0.0 0.5 1.0
RSA
Av
ia
n 
H
1 
dN
/d
S
5e−03
5e−02
5e−01
5e+00
OR = 2.5, p = 0.0084
0.0 0.5 1.0
RSA
Av
ia
n 
H
3 
dN
/d
S
5e−03
5e−02
5e−01
5e+00
OR = 1.2, p = 0.73
0.0 0.5 1.0
RSA
Av
ia
n 
H
5 
dN
/d
S
Figure 3.2: Per-site evolutionary-rate ratios ω = dN/dS plotted against RSA.
Each dot represents the ω REL estimate for a single site. Red dots highlight
sites in the sialic-acid binding region (SABR sites). Solid lines represent regres-
sion lines of ω against RSA, with associated 95% confidence bands. Dashed
lines represent ω = 1. OR stands for the odds ratio that sites in the sialic-acid
binding region fall above the regression line, with associated p value calculated
by Fisher’s exact test.
To assess how variation in ω correlated with protein function, we next
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compared ω of sites near the sialic-acid binding region to the ω of other sites.
We considered sites to be near the sialic-acid binding region if the correspond-
ing residue had at least one atom within 8A˚ of the sialic-acid molecule in our
reference PDB structure. There were 39 such sites. In the following, we will
refer to these sites as SABR (Sialic Acid Binding Region) sites. The cutoff of
8A˚ is conservative, in the sense that we likely captured all sites relevant for
sialic-acid binding as well as some sites that are not. Thus, even if the entire
sialic-acid binding region was under positive selection, we would not expect
all 39 SABR sites to have elevated ω. However, we would expect this set of
sites to be enriched for sites with elevated ω relative to other regions in the
protein.
Visual inspection of Fig. 3.2 reveals that SABR sites have elevated ω
for both human and avian viruses for most HA subtypes. We quantified this
association by estimating how much more likely a SABR site was to fall above
the ω–RSA trendline than below the trend line. With the exception of avian
H5, odds ratios (OR) fell between 2.5 and 3.3 (Fig. 3.2) and were significantly
different from 1 (Fisher’s exact test). In avian H5, we found no evidence for
elevated ω in SABR sites.
3.3.3 Site-specific ω estimates vary substantially among host species
and HA subtypes
We next assessed to what extent site-specific evolutionary-rate ratios
were comparable across species. We found that while there was a clear trend
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towards similar ω across species, variation around this trend was substantial
(Fig. 3.3). Correlation coefficients fell between 0.49 and 0.6. Thus, between
24% and 36% of the variation in ω for one host species was explained by
the ω values of sequences infecting another host species. More specifically,
in any given comparison, strong negative selection (low ω) in one group did
not guarantee strong negative selection in another group. Several of the most
constrained sites in avian sequences had ω near or above 1 in human sequences
(Fig. 3.3).
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Figure 3.3: Per-site evolutionary-rate ratios ω = dN/dS plotted for pairs of
species. Each dot represents the ω REL estimate for a single site. Red dots
highlight sites in the sialic-acid binding region (SABR sites). Dashed lines
indicate the x = y line, and solid lines indicate the direction of maximum
covariation in each data set. The correlation coefficients r represent Pearson’s
correlations, calculated for logω. OR stands for the odds ratio that sites in
the sialic-acid binding region fall below the solid line, with associated p value
calculated by Fisher’s exact test. (Significance levels: ∗p < 0.05; ∗∗∗p < 10−4.)
Despite the overall finding that conservation in one group does not guar-
antee conservation in the other group, most comparisons also showed clusters
of sites with very similar (and typically low) ω values. Thus, there seems to
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be a core set of conserved sites that are shared among strains.
We found systematic differences in H1 and H3 across host species; ω
estimates for avian H1 and H3 were generally lower than the corresponding
estimates for human H1 and H3 (Fig. 3.3). Human and avian H5, on the other
hand, showed virtually no difference in ω on average.
For SABR sites specifically, we found that their ω differences were
mostly in agreement with the overall ω differences of the strains compared.
We tested whether SABR sites were more likely to fall either above or below
the lines of maximum covariation in Fig. 3.3, using Fisher’s exact test as be-
fore. For H1 and H3, we could not reject the null hypothesis of an odds ratio
of 1. However, we did find that SABR sites evolved at a significantly elevated
ω in human H5 compared to avian H5.
3.3.4 Differences in ω are moderately biased towards the protein
core
Finally, we wanted to assess whether the largest differences in ω among
groups associated with specific regions in the structure. To this end, we in-
troduced a function G, defined as G(1, 2) = | log(ω1/ω2)|, which measures the
absolute difference in logω at a site. We plotted G as a function of RSA to
determine whether the largest differences occurred on the protein surface or
in the core (Fig. 3.4).
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Figure 3.4: Cross-species rate differences as a function of RSA. The function
G(1, 2), defined as G(1, 2) = | log(ω1/ω2)|, is plotted against RSA. Correlation
coefficients are Spearman correlations between G and RSA. The function G is
negatively correlated with RSA for H1 and H3, and positively correlated for
H5. Red dots highlight sites in the sialic-acid binding region (SABR sites).
We found a weak trend of declining G with increasing RSA in H1 and
H3, and the opposite in H5 (Fig. 3.4). Thus, for H1 and H3, sites in the core of
the protein showed, on average, slightly larger differences in ω than sites near
the surface. This finding suggests that ω differences among strains are not just
caused by different antigenic pressure (which would exert itself on the surface
of the protein) but also by some processes that act throughout, and possibly
particularly towards the core of, the protein structure. The inverted trend for
H5 may indicate that in these viruses, the difference between the avian and the
human selective environment is indeed dominated by surface-bound processes
(antibody binding and/or sialic-acid binding).
We mapped the SABR sites onto theG–RSA plots to determine whether
they were contributing to an excess of buried sites with high ω in humans.
Clearly, many of the SABR sites have relatively low RSA (Figs. 3.2 and 3.4).
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However, no obvious trend emerged. SABR sites did not cause the negative
correlation between G and RSA observed for H1 and H3.
3.4 Discussion
We have found that protein structure makes a significant contribution
to per-site evolutionary rate variation in influenza hemagglutinin. We have
also found that sites near the sialic-acid binding region show elevated ω in
most strains. Finally, we have found that site-specific rate variation among
different influenza strains is comparable but by no means identical. This find-
ing emphasizes the diverse nature of strain and host-specific selection pressures
throughout the HA protein.
The strength of the correlations among ω for different host species
inform us about the extent to which protein structure constrains sequence
evolution. If protein structure were entirely responsible for any rate variation,
then these correlations should be near 100%. By contrast, if protein structure
had no influence on sequence variation, then these correlations should be near
0% (to the extent that evolution has truly been restricted to only one host
species). We found that the ω values of sequences for one host species explained
between 24% and 36% of the variation in ω for sequences of another host species
(correlation coefficients fell between 0.49 and 0.6). Thus, at least 60%, and
possibly more, of the variation in ω is not explained by protein structure.
We found that all viral strains except avian H5 experienced elevated ω
in the sialic-acid binding region. This finding likely reflects diversifying selec-
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tion in this region, driven by antibody escape or HA–receptor interactions. In
humans, antibodies are not generally thought to bind at the sialic-acid binding
region, yet such antibodies do exist and may be sufficiently common to drive
positive selection in this region [103]. Further, the sialic-acid binding region is
small compared to the typical binding region of an antibody. Thus, mutations
in the periphery of the receptor pocket can interfere with antibody binding
without inhibiting sialic-acid binding [103]. Second, the positively selected
mutants may not primarily be antibody-escape mutants but rather mutants
that change the avidity of HA–receptor interactions [41]. Such substitutions
could be driven by sequential passage in immune and naive hosts, for example
human adults and human children, where immune hosts select for increased
avidity and naive hosts select for decreased avidity [41].
In our comparison of strains infecting different host species (Figure 3.3),
we found for H1 and H3 that evolutionary-rate ratios ω in the sialic-acid bind-
ing region were consistent with the overall differences in evolutionary rates
among host type. For example, the comparison of avian to human H3 shows
that avian H3 is overall more conserved than human H3, and this increased
conservation is visible in similar magnitude near the sialic-acid binding region
and elsewhere in the protein. Further, both the H1 and the H3 comparison
show clear clusters of sites that are conserved in both strains but overall more
conserved in one strain than in the other (i.e., clusters are shifted away from
the dashed line representing equal ω). Note that this result is not likely to
be caused by mutation-rate differences, since ω = dN/dS is normalized for
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mutation rate. In combination, these findings suggests that there are sys-
tematic differences in selection pressures among human and avian influenza
strains. These altered selection pressures seem to operate throughout the en-
tire protein, not just in specific regions. Previous studies have shown that
the sialic-acid binding region is more conserved in avian viruses than in hu-
man viruses [63]. Our results do not disagree with this previous observation,
but they suggest that this observation may have been caused by selection pres-
sures acting on the entire HA protein, rather than by selection pressures acting
specifically on the antigenic regions of the protein.
It was surprising that human and avian H5 sequences showed substan-
tial differences in their evolutionary patterns, and in particular, that sites in
the sialic-acid binding region showed elevated ω in human H5 compared to
avian H5. In contrast to H1 and H3, human and avian H5 sequences can-
not be considered distinct viral lineages. Because H5 cannot be transmitted
directly among humans, one would expect that human H5 sequences should
look like a random sample of avian H5 sequences. Yet this was not the case.
In particular, sites in the sialic-acid binding region evolved significantly dif-
ferently in human and avian H5. There are two possible explanations for this
observation: First, the human physiology starts exerting a selection pressure
on the sialic-acid binding region as soon as a human is infected with H5, and
the H5 sequences evolve significantly within patients. Second, and more likely,
only a subset of H5 sequences, in particular sequences with specific changes
in the sialic-acid binding region, can infect humans. Therefore, human H5
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sequences are not a random sample from avian H5 sequences. Prior work has
shown the accumulation of key adaptive substitutions after introduction of
avian H1, H2, and H3 to mammalian hosts [62]. The methods we used here
are not suitable to identify key substitutions in H5 adaptation from avian to
human hosts; however, suitable methods exist [54] and could be applied to this
problem in future studies.
A number of prior studies have looked at adaptive evolution in in-
fluenza HA, using both dN/dS-based methods (e.g. [15, 94, 106]) and other
methods (e.g. [8, 54, 96]). However, a site-by-site comparison across different
host species, as we have performed here, is not usually done. One exception
is the recent work by Tamuri et al. [96], who identified sites under differen-
tial selection pressure in human and avian influenza. Their results are broadly
consistent with ours. The majority of sites showed no significantly different se-
lective constraints among human and avian sequences. Nevertheless, a number
of sites did show significant differences. For H3, Tamuri et al. [96] identified 11
such sites. This number seems low relative to the large amount of ω differences
between human and avian H3 we found here. Several issues may contribute
to this apparent discrepancy: (i) only 11 sites were identified with high confi-
dence by Tamuri et al., more sites were identified at lower confidence; (ii) we
did not attempt to identify for which sites ω was significantly different among
species here; while we saw a substantial amount of variation in ω, some of
this variation may not be statistically significant; (iii) Tamuri et al.’s and our
model are fundamentally different and may identify different sites.
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To assess whether sites in the sialic-acid binding region had elevated ω,
we used Fisher’s exact test instead of a seemingly more natural linear regression
of ω against RSA and site type. We decided against the regression analysis
because ω is a derived quantity, estimated from a model that used RSA as
input data. Therefore, the regression analysis could potentially yield incorrect
results. By contrast, for any chosen bisection of the data, Fisher’s exact test
answers the question whether SABR sites are enriched on one side of the
bisection. Thus, even if the trendlines in Fig. 3.2, derived from a regression,
are not entirely correct, we can conclude that SABR sites are significantly
enriched above the trendlines for all strains except avian H5. One caveat
of this application of Fisher’s exact test is that we are treating ω values as
observations, even though they are noisy estimates. The noise on ω reduces the
power of Fisher’s exact test; however, we do not expect the noise to artificially
inflate the rate of false positives.
We fitted both RSA-dependent and RSA-independent models to all
alignments, and found that in all except one case the RSA-dependent model
produced the better fit. Due to the way we chose to weight per-site evolutionary-
rate estimates by each site’s posterior probabilities, in all cases ω estimates
obtained by RSA-independent models were highly correlated with ω estimates
obtained by RSA-dependent models (Table 3.1). Hence, rather than explicitly
defining an RSA-dependent model, one could make estimates within an RSA-
independent framework; then, structural information could be inferred in post-
analysis by taking into account partial occupancy of multiple rate categories
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for each site in the protein. Our analysis shows that incorporating structure
in this way produces less accurate rate estimates than when the structure is
already known. However, for future studies, this finding also suggests that
even when analysis in a structural context is desired, it may be sufficient to
first calculate evolutionary rates without structural input and then correlate
these rates with structural features. While rates calculated with structural
input are expected to be more accurate, and can reveal aspects of the data
that might have remained obscure otherwise [66], there are likely many appli-
cations where the saved computational expense of not fitting structure-aware
models is worth the small loss in the accuracy of estimates.
Throughout our analysis, we assumed that the protein structure (and
hence RSA) remains constant over time and even across HA subtypes. This
approximation is reasonable, because hemagglutinin is a structurally homo-
geneous protein; available crystal structures show little structural variation.
The full-length form of hemagglutinin, referred to as HA0, consists of over 500
amino acids. Prior to capsid incorporation and viral burst, HA0 is cleaved into
two proteins, HA1 and HA2. Comparing all structures available in the protein
database (over 100, both pre- and post-cleavage), we found that greater than
90% of the two post-cleavage subunits varied by less than 2 A˚ RMSD (not
shown). Moreover, most of that variation was the result of flexible regions
near chain terminations. Several post-cleavage structures exist; they tend to
have very different structures near the inter-chain break site of HA0, due to
the additional chain terminations. To eliminate the unpredictable variation
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near the site of inter-chain termination, we chose to base our RSA calculations
on an HA0 crystal structure. Since the cleavage site is in the transmembrane
domain of HA, approximately 80 A˚ away from the sialic-acid binding region,
we do not expect any structural variation in this region to impact our results
in any substantive way. Finally, we used a high quality structure from H1
influenza throughout this work, because there were no suitable, full-length H3
or H5 HA0 structures.
The high evolutionary conservation of hemagglutinin structures across
subtypes and host-species implies that the immune systems of humans and
birds do not generally rely on the 3-dimensional structure of hemagglutinin
for binding, but only on the specific sequence of amino acids that is overlayed
on that structure. If structure itself were important for immunogenicity, we
would expect to see large structural deviations as the host immune system
pressured influenza to escape neutralization.
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Chapter 4
Evaluating the effect of mutations in a
protein–protein interaction
4.1 Introduction
This work was published previously in the journal PeerJ.1The computa-
tional prediction of mutational effects on protein–protein interactions remains
a challenging problem. Several methods are available to perform an energy
difference calculation from an experimentally determined co-crystal structure.
For example, end point methods can be performed rapidly, with relatively low
computational cost [37, 50]. However, such methods can suffer from various
simplifying assumptions. For example, they generally use an implicit solvent
approximation and assume the end state difference with minimal structural
rearrangement is sufficient to discriminate energetic differences [37, 50]. Al-
ternative approaches have been developed using machine learning, training
coefficients in a weighted equation containing geometric and energetic pa-
rameters [4, 44, 100, 101]. Unfortunately, such machine-learning approaches
often suffer in novel applications, for which available training sets are small
1A. G. Meyer, S. L. Sawyer, A. D. Ellington, and C. O. Wilke. Analyzing machupo virus-
receptor binding by molecular dynamics simulations. PeerJ, 2:e266, 2014. S. L. Sawyer, A.
D. Ellington, and C. O. Wilke helped to design the project and write the manuscript.
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or non-existent. As such, these methods are poorly suited for most host-virus
protein–protein systems. By contrast, first principles methods can forgo train-
ing, but currently available methods such as free energy perturbation (FEP)
and thermodynamic integration (TI) rely on a transitional model (where one
state may be wild-type and the other may be a mutant) to make rigorous
free energy calculations [18, 31, 40, 61]. While these may be considered two of
the gold standard techniques for calculating affinity differences, there are a
huge number of theoretical and technical complexities that must all be prop-
erly managed to ensure a converged solution [39]. Such considerations quickly
come to dominate the protocol, and the necessary book keeping introduces
the possibility of human error [39]. Moreover, as the two ending states look
ever more dissimilar the chances of convergence fall rapidly. To ensure conver-
gence, these techniques are typically limited to small differences (such as point
mutant comparisons) with a few, very impressive exceptions [39, 40, 102]. For
most investigators, larger differences quickly become intractable as the num-
ber of intermediate steps required to compute a converged solution grows or
the complexity of adding restraining potentials and computing approximations
expands [39,40,102].
Here we propose that much of these complexities can be avoided if all
we are interested in is a relative comparison of the effects of different mutations
on protein-protein interactions, rather than measuring an absolute or relative
binding affinity with experimentally realistic units. We impart a pulling force
within an all-atom molecular dynamics simulation on one member of the com-
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plex while the other is held in place. Then, we measure the force required
for dissociation [38, 45, 46, 60, 71, 73]. Although such biasing techniques are
commonly used in protein-ligand binding problems, they are less commonly
applied to protein–protein interactions, and almost never to mutational anal-
ysis in a protein–protein system. This is largely the result of free energy
convergence difficulties and computational limitations [22, 23]. Using a proxy
for relative binding affinity rather than calculating absolute affinities can solve
these problems. Here, as proxies, we use the maximum applied force required
for separation and the area under the force-versus-distance curve (AUC). For
comparison, we also calculate relative free energy differences using the tradi-
tional dual topology FEP paradigm, and we show that the two approaches
yield congruent results.
We used SMD and FEP to interrogate the interaction between machupo
virus (MACV) spike glycoprotein (GP1) and the human transferrin receptor
(hTfR1) [1, 17]. Machupo virus is an ambisense RNA virus of the arenavirus
family [17]. Worldwide, arenaviruses represent a significant source of emerging
zoonotic diseases for the human population [17]. Members of the arenavirus
family include the Lassa fever virus endemic to West Africa, the lymphochori-
omeningitis virus (LCMV) endemic to rodents in several areas of the United
States, and the Guanarito, Junin, and Machupo viruses endemic to rodents
in South America [17]. The South American arenaviruses typically infect hu-
mans after rodent contamination and can cause a devastating hemorrhagic
fever with high mortality [17].
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The hTfR1 is the primary receptor used by MACV for binding its host
cell prior to infection. The primary role of hTfR1 in vivo is to bind transferrin
for cellular iron uptake. The hTfR1 protein contains three extracellular do-
mains: two basilar domains and an apical domain. The two basilar domains
serve most of the transferrin-binding function [1,79]. Viral entry is initiated by
GP1 binding to the apical domain of hTfR1. Previous work has indicated that
the GP1/hTfR1 binding interaction is the primary determinant of MACV host
range variation [19, 79]. The co-crystal structure shows that the high affinity
interaction between GP1 and hTfR1 forces the normally flexible loop in the
apical domain of hTfR1 into a rigid β-pleated sheet domain. For GP1, several
extended loops mediate binding to hTfR1 [1, 79], and many of the interface
interactions are mediated by extensive hydrogen-bonding networks [1]. Ex-
perimental alanine-scanning and whole-cell infectivity assays have identified
several sites in both GP1 and hTfR1 that are probably critical for establishing
infection [19,79].
We applied our computational method to wild type (WT) and mutant
complexes, and found that we could resolve relative differences in unbinding
and predict significant affinity changes. Importantly, the affinity changes pre-
dicted using only max force or AUC show a strong correlation with rigorous
relative free energy differences computed by FEP. At sites known to be impor-
tant for successful viral entry, we found that the biochemical cause of reduced
infectivity may not be as simple as the static structure suggests. For example,
the static structure shows a hydrogen-bonding network connected to site N348
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in hTfR1. According to our simulations, this network may not affect binding
affinity directly. In addition, our study offers an all-atom steered molecular
dynamic approach to avoid some of the pitfalls of several existing methods
used to evaluate mutations in protein–protein interfaces.
4.2 Materials and Methods
4.2.1 System Modeling
For our experiments, we used the experimentally determined GP1/hTfR1
structure (PDB-ID: 3KAS) [1]. The apical domain of hTfR1 interacts directly
with GP1 while the other two domains are closer to the cell membrane and
have essentially no interaction with GP1. The biophysical independence of
the apical domain allowed us to isolate it without significantly affecting the
GP1/hTfR1 interaction.
We used the protein visualization software PyMOL [87] to remove
residues 121-190, 301-329, and 383-756 in the hTfR1. No residues were re-
moved from the viral protein. Figure 4.1 shows a model of the initial structure
and that of the pared structure. Although GP1 has several glycosylatable
residues, we opted to use the de-glycosylated protein for this study. The
complexity of correctly parameterizing diverse sugar moieties is outside of the
scope of this paper. Furthermore, although it is known that GP1 is glyco-
sylated, and some of those sugars contact hTfR1, the sugars in the available
PDB structure are not physiological for mammals [1]. In total we removed 10
sugars from the crystal structure for this study.
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Figure 4.1: The GP1/hTfR1 complex. GP1 is shown in blue and hTfR1 is
shown in green. (A) The full, de-glycosylated GP1/hTfR1 co-crystal structure.
(B) The reduced structure used in SMD simulations.
After system reduction, the Visual Molecular Dynamics (VMD) [43]
package along with its system of back-ends was used for all subsequent model-
ing. The Orient add-on package allowed us to rotate the system axis such
that the direction of steering was oriented directly down the z-axis. De-
glycosylation simplified the system such that Autopsf could easily find the
chain terminations and patch them appropriately. The Solvate package was
used to generate a TIP3P water model with a 5 A˚ngstrom buffer (relative to
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the maximum dimensions of the proteins) on all sides except down the positive
z-axis where a 20 A˚ngstrom buffer was created. Finally, we used the Autoionize
package to place 150 millimolar NaCl and neutralize the total system charge.
In the end, each modeled system had approximately 28,000 atoms.
4.2.2 Equilibration
NAMD was used for all simulations in this study [75]. In addition to
the modeled system, for equilibration we generated a configuration file that
fixed the α-carbon backbone. This was accomplished by setting the B-factor
column to 1 for the fixed atoms and to zero for all other atoms. Further,
we generated a configuration file with fixed α-carbon atoms at residues 41-92
(numbered linearly, in this case, starting at 1 for the first amino acid as was
required for NAMD) in the hTfR1. The second file was used to affix a har-
monic restraint, thus preventing any unfolding due to system reduction. More
importantly, the harmonic restraint allowed the protein complex to equilibrate
while preventing any drift from its predefined position; the restraint did not
constrain the structure of each protein, or the relative position or orientation
of the two proteins to each other. Finally, we calculated the system center
and dimensions for use in molecular dynamics settings. The exact NAMD
configuration files are available on github
(https://github.com/clauswilke/MACV SMD).
We used the Charmm27 [12] all-atom force field. The initial system
temperature was set to 310K. Several typical MD settings were used including
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switching and cutoff distances (see provided configuration files). In addition,
we used a 2 femtosecond time step with rigid bonds. We used periodic bound-
ary conditions with the particle mesh ewald (PME) method of computing full
system electrostatics outside of the explicit box. Furthermore, we used a group
pressure cell, flexible box, langevin barostat, and lavegin thermostat during
equilibration. A harmonic restraint (called harmonic constraint in VMD) was
set as stated previously.
To start the simulation, the barostat was switched off and the system
was minimized for 1000 steps. Next, the fixed backbone was released, and the
system was minimized for an additional 1000 time steps. Subsequently, the
system was released into all-atom molecular dynamics for 3000 steps. Finally,
the langevin barostat was turned on and the system was simulated for 2 ns
(1,000,000 steps) of chemical time. For each mutant, twenty independent
equilibration replicates were run with an identical protocol.
4.2.3 Steered Molecular Dynamics
We used the final state from each equilibrated system to restart another
MD simulation. Our steering protocol is fundamentally similar to [22] with
slightly different parameter choices. Perhaps the one significant difference
lies in our choosing to not use a thermostat or barostat. We can make this
choice because we are not trying to calculate the binding free energy by any
physically rigorous approach (the Jarzynski inequality being one example).
Following equilibration, the final state of each simulation was used to generate
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a configuration file fixing the α-carbon on residues 1, 58, 73-83, 96, 136, 137,
138, and 161 (again with linear numbering) in the hTfR1. These residues were
selected as they are far from the binding interface and sufficiently distributed
to prevent any orientational motion of the receptor relative to the viral spike
protein. The center of mass of the α-carbons of all residues (163-318 in linear
numbering) in GP1 received an applied force during the simulation. The
NAMD convention does not actually apply a force to all α-carbon atoms but
rather uses the selection to compute an initial center of mass. Then, during
the steering run, the single center of mass point is pulled with the parameters
described below. We used the same force field parameters (exclude, cutoff,
switching, etc.), the same integrator parameters (time step, rigidbonds on, all
molecular being wrapped, etc.), and the same particle mesh ewald parameters
as in equilibration. Periodic boundary conditions were incorporated as part of
the system (as is the convention in NAMD restart) and PME was again used
to approximate full system electrostatics.
We ran test simulations at several force constants and visually inspected
the results. A force constant of 5 kcal/mol/A˚2 was chosen due to its relatively
low signal-to-noise ratio. This constant is slightly lower than the more common
7 kcal/mol/A˚2 found in several recent studies; that value is commonly selected
primarily because it is the force constant found in the SMD tutorial available
through the NAMD developers. Moreover, the force constant could very likely
be set to a range of nearby values with little loss in predictive power.
In SMD experiments the pulling velocity should be as low as possible for
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the available computational time [22,23]. We choose a velocity of 0.000001 A˚/fs
= 1 A˚/ns, and direction down the positive z-axis. One could use faster pulling
if the computing time must be reduced, but slower than necessary pulling
speeds are not typically considered problematic.
SMD was run for 15 ns (7,500,000 time steps) of chemical time. For
each simulation, we randomly selected one of the equilibration runs for restart.
We ran 50 replicate simulations per mutant for a total of 550 SMD simulations.
All GP1/hTfR1 complexes separated by greater than 4 A˚ and many separated
to 10 or more.
To leave the final trajectory of a tractable size, only 1000 evenly spaced
frames were retained from each simulation, leaving a final trajectory size of 323
MB. See the supplemental movie for a representative unbinding trajectory. Ini-
tial development of the SMD protocol was carried out on the Lonestar cluster
at the Texas Advanced Computing Center (TACC). All production SMD simu-
lations were performed on the Hrothgar cluster at Texas Tech University, using
NAMD 2.9. Each simulation was parallelized over 60 computational cores and
utilized approximately 20 hours of computing time. The total chemical time
simulated for this project was nearly 10 µs, requiring slightly over 1 million
cpu-hours.
4.2.4 Free Energy Perturbation
Briefly, we used the traditional dual topology approach to FEP [30,74].
This involves a thermodynamic cycle where a set of atoms are progressively
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decoupled from the environment while another set of atoms are progressively
coupled. To compute the relative free energy difference requires knowing the
free energy change when the transformation is carried out for the bound com-
plex and the individual protein. Then, one can compute the relative free
energy difference between a WT and mutant complex by taking the difference
between the energy required to decouple/couple the atoms in solution from the
energy required to decouple/couple the atoms in the bound complex [30,74].
Again, the NAMD configuration file is made available via github
(https://github.com/clauswilke/MACV SMD). We used a similar configura-
tion to that in equilibration. One significant difference was to make a cubic
water box with a side length equal to the long axis of the complex plus a
10 A˚ buffer on either side, and simply restrict center of mass motion with
the NAMD setting. This was done to avoid affecting the system energy while
calculating free energy differences.
The transition protocol for bound and free protein systems were iden-
tical. They started with 1000 steps of minimization and 250,000 steps of equi-
libration in the starting state for the forward and reverse directions. Phase
transitions were carried out in steps of λ=0.05. Each transition was carried out
for 250,000 steps. The first 100,000 steps after phase transition were reserved
for equilibration and the final 150,000 steps were used for data collection.
The VMD mutator tool was used to generate the necessary topology
file and the parseFEP tool [59] in VMD was used for subsequent analysis. We
used it to perform error analysis and compute the Bennett acceptance ratio as
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the maximum likelihood free energy difference of the two states under consid-
eration. Though the larger transitions presented difficulty in a small number
of windows, forward and reverse hysteresis was generally in good agreement for
all complexes. The double mutants were performed by first doing the Y211A
mutation followed by the other of the two mutants. Then, the ∆G’s were
simply added together to get the total energetic difference.
4.2.5 Post-processing
The python packages MDAnalysis [67] and ProDy [5] were both used
at various points in post-processing. The molecular trajectory (comprising
the atomic coordinates per time) was parsed to compute the center-of-mass
for each of the two complexes. The starting center-of-mass distance was set
to zero and the distance was re-computed at each time step relative to the
starting distance.
The statistical package R was used for all further analysis and visual-
ization. Each of the 50 independent trajectories per mutant produced a fairly
noisy force curve. The force curves for each mutant were smoothed over all
replicates by using the smooth.spline() and predict() functions in R with de-
fault settings. The two primary descriptive statistics we used were maximum
interpolated applied force and total area under the interpolated curve (AUC).
We tested for signifiant differences in maximum force or AUC by carrying out
t tests for all pairwise combinations (each mutant compared to each other
mutant), using the pairwise.t.test() function in R. We adjusted p values to
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correct for multiple testing using the False-Discovery-Rate (FDR) method [7].
The ggplot [104] package was used to generate most of the figures.
Analysis scripts and final data (except MD trajectories) are available
on the github repository accompanying this publication
(https://github.com/clauswilke/MACV SMD).
4.3 Results
4.3.1 The GP1/hTfR1 system
The GP1/hTfR1 interface (Figure 4.2) marks a particularly important
and useful test system. There are several sites on both the human and viral
protein known to affect the infectivity phenotype of MACV. Many of the im-
portant sites have been mapped by in vitro flow-cytometry based entry assays.
The GP1/hTfR1 interface appears not to be dominated by one particular type
of interaction (electrostatics, hydrogen-bonding, or van der Waals). In addi-
tion, much of the binding domain on hTfR1 is on a loop that is flexible prior
to viral binding, but organizes to become a strand of a β-sheet on binding.
As a result, many other computational techniques [37,50] are only marginally
useful. The complex nature of this interface represents a particularly difficult
challenge for traditional computational analysis.
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Figure 4.2: The two hydrogen bonding networks. GP1 is shown in blue and
hTfR1 is shown in green. (A) The first network including Y211 and R111 is
shown in white, and the second network containing N348 is shown in pink.
(B) Near view of the first network with contacts in yellow. (C) Near view of
the second network with contacts in yellow.
In total, we tested 7 point mutants and 3 double mutants in addition
to the WT complex (Table 4.1). All of the mutations are within 5 A˚ of the
protein–protein interface. Mutations in hTfR1 at site 211 have proven capable
of causing loss-of-entry according to in vitro flow-cytometry infection assays
or known host-range limitations [19,78,79]. Most likely, this effect is caused by
the destruction of a critical hydrogen bond to Ser113 or Ser111 in GP1. The
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lost hydrogen bond would lead to the subsequent loss of a large hydrogen-
bonding network seen in the crystal structure (Table 4.1) [1]. In a manner
similar to site 211, N348 appears to be important for binding by participating
in a critical hydrogen bonding network [1,78] to GP1. In particular, N348Lys
is reported in the literature to cause significantly reduced viral entry in vivo
(Table 4.1) [1, 78]. Finally, an alanine mutation at site 111 in GP1 (mutation
vR111A) has also been shown to cause decreased entry (Table 4.1) [79]. For
notation purposes, the viral site is always referred to with a preceding ‘v’.
Table 4.1: Summary of prior information available for each mutation tested.
Observed in vivo refers to mutations that have been observed in rodent popu-
lations. Phenotype in vitro refers to the observed phenotype in in vitro viral
entry assays.
Mutation Observed in vivo Phenotype in vitro
WT Yes Normal Entry
N348A No -
N348K Yes Diminished Entry
N348W No -
vR111A No Diminished Entry
N348A/Y211A No -
vR111A/Y211A No -
Y211D Yes No Expression
Y211T No Diminished Entry
Y211A No No Expression
N348W/Y211A No -
Despite the fact that viral binding occurs at the site of a flexible loop in
the free hTfR structure, our data shows after binding the strand is extremely
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rigid. In the bound conformation, only two sites of the loop have root mean
squared fluctuation (RMSF) values in the top half of all receptor sites during
equilibration (Figure 4.3), and those are almost completely exposed to solvent.
This is unsurprising considering the high degree of burial that occurs as a result
of viral binding. Computing the root mean squared deviation (RMSD) of the
entire structure over the trajectory shows that none of the mutations are so
deleterious as to cause rapid unbinding. In fact, the RMSD over trajectory
looks highly invariant across mutants (Figure 4.4). In the unbound state,
calculated near the end of the SMD trajectory, all of the residues in the WT
receptor interfacial strand are in the top half of RMSF over all receptor sites
(Figure 4.5). Thus, if sufficient simulation time is not dedicated to allowing
this unfolding process, standard free energy techniques may miss the energetic
contributions that result from ordering the flexible loop in the hTfR apical
domain.
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Figure 4.3: RMSF values during equilibration. The RMSF values for every
site in the bound complex computed during the equilibration phase of the
protocol. Each color represents the average over 20 trajectories of a single
mutant. Indices 17-25 are the hTfR flexible loop. The plot shows the flexibility
of each site is essentially independent of mutation, and two sites (indices 17 and
18) above 0.72 A˚ are a part of the flexible loop in the free receptor. However,
these two residues are not actually found in the protein–protein interface, but
rather are almost completely solvent exposed with the virus bound.
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Figure 4.4: RMSD values during equilibration. The RMSD values over the
time of the trajectory computed during the equilibration phase of the protocol.
Each color represents the average over 20 trajectories of a single mutant. The
plot shows none of the mutants causes immediate unbinding of the protein–
protein complex. In addition, the universal upward trend near the end of the
equilibration trajectories may indicate the crystal is more tightly packed than
would normally occur in solution.
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Figure 4.5: RMSF values of WT hTfR in equilibration and SMD. The RMSF
values for every site in the WT receptor were computed during the equilibra-
tion phase and during final 50 frames of the SMD trajectories. The black line
was computed over equilibration and the red line during SMD. The plot shows
the solution mobility of the hTfR flexible loop increases more than the average
during the unbinding process.
4.3.2 Molecular dynamics simulations
We analyzed the GP1/hTfR1 system using two molecular dynamics
techniques. First, by carrying out SMD using a known force constant and
81
pulling with a constant velocity, we could calculate the applied force during
protein–protein dissociation [22,23]. A typical averaged force curve comparison
can be seen in Figure 4.6, and individual images of all averaged force curves are
available in the associated github repository, in folder figures/force curves. As
seen in Figure 4.6, the dissociation distance was relatively consistent among
mutants. The supplementary movie visually illustrates the separation distance
between peptide domains. The quantities maximum applied force and AUC
were derived from the force-versus-distances curves. Their summary statistics
are reported in Table 4.2. As we are more interested in the phenotypic impact
of interface mutations we avoided many of the more physically rigorous, but
technically complicated calculations that are possible with SMD [45,46].
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Figure 4.6: Force versus distance curve of WT and the Y211A mutant. The
average force curve for 50 replicates of the WT complex is shown in black, and
the average of 50 replicates of the Y211A mutant is shown in red. There is
a large difference in both maximum applied force and AUC between the two
complexes.
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Table 4.2: Summary statistics for each mutation tested. µMAF is the mean
in piconewtons and σMAF is the standard deviation of maximum applied force
over all simulations. µAUC is the mean and σAUC is the standard deviation
of AUC over all simulations. ∆G is the free energy difference in kcal/mol
calculated via FEP by the dual topology paradigm.
Mutation µMAF (pN) σMAF µAUC σAUC ∆G (kcal/mol)
WT 734.4856 131.6513 145460.4 60232.26 0.000
N348A 748.5217 137.4864 133913.9 51078.64 -2.149
N348K 705.0707 108.5079 141084.4 54450.28 +3.184
N348W 697.3642 132.6436 136886.0 53796.44 +3.033
vR111A 713.8081 106.7374 136103.2 52070.85 +0.466
N348A/Y211A 703.7027 128.5866 113464.2 57451.62 +5.203
vR111A/Y211A 741.0642 131.6287 130070.6 47665.56 -2.440
Y211D 825.2586 115.4343 158878.7 63039.08 +2.760
Y211T 806.8593 136.5648 167110.7 78849.29 +0.875
Y211A 654.1138 108.5343 108090.0 43661.09 +2.526
N348W/Y211A 594.9044 134.8233 108984.2 45451.00 +8.206
Before systematically applying SMD to the GP1/hTfR1 interaction, we
needed to ensure the method was sufficiently sensitive to distinguish between
relatively minor point mutations. While SMD has been applied previously to
measure the binding energy of high-affinity T-cell receptor interactions [22,23],
it is rarely used to parse small energy differences in a protein–protein interac-
tion energy landscape. For this initial sensitivity analysis, we tested alanine
substitutions congruent with the traditional experimental and computational
approach.
We proceeded to compare our SMD results to that of the standard dual
topology FEP approach to calculate relative free energy differences. The cor-
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relation between the energetically rigorous FEP and our statistical approach is
high. For all 11 complexes tested, the correlation between max force and FEP
was r = −0.795 at p = 0.0034 (Figure 4.7), and the correlation between AUC
and FEP was r = −0.593 at p = 0.055. Because of the strong correlation, we
refer exclusively to the SMD results for the remainder of this work, focusing
primarily on max force.
l
l
l
l
l
l
l
l
l
l
l
600
700
800
−4 −2 0 2 4 6 8
Free Energy Perturbation (kcal/mol)
In
te
rp
ol
at
ed
 M
ax
im
u
m
 F
o
rc
e
 (p
N)
Figure 4.7: Max force versus free energy perturbation. Scatter plot of maxi-
mum force in SMD versus the relative free energy difference calculated by FEP
for all 10 mutants tested plus the WT complex. The WT complex for FEP
was simply set to 0.0. The correlation between the two is r = −0.795 with
p = 0.0034.
We found that relative to WT, one alanine mutation (Y211A) produced
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a very large and statistically significant difference in the maximum applied
force and AUC (Figure 4.6, Table 4.3), while the other two did not (Table 4.3).
When considering additional mutants (also discussed below), we found that
maximum applied force was generally sufficient to distinguish mutants (Ta-
bles 4.3 and 4.4), and AUC was able to add a few more statistically significant
differences (Table 4.5). In general, however, and consistent with the FEP re-
sults, maximum applied force seemed to be the more sensitive statistic than
AUC.
Table 4.3: Pairwise differences (row variable minus column variable) in mean
maximum applied force. Bolded values are statistically significant at p < 0.05.
WT N348A N348W N348K vR111A N348A/Y211A vR111A/Y211A Y211D Y211T Y211A
N348A +14.036
N348W -29.414 -43.451
N348K -37.121 -51.157 -7.7060
vR111A -20.677 -34.713 +8.7370 +16.443
N348A/Y211A -30.782 -44.819 -1.3670 +6.3380 -10.105
vR111A/Y211A +6.5790 -7.4570 +35.993 +43.700 +27.256 +37.361
Y211D +90.772 +76.736 +120.19 +127.89 +111.45 +121.56 +84.194
Y211T +72.373 +58.337 +101.79 +109.50 +93.051 +103.16 +65.795 -18.399
Y211A -80.371 -94.407 -50.956 -43.250 -59.694 -49.588 -86.950 -171.1 4 -152.75
N348W/Y211A -139.58 -153.62 -110.17 +102.46 -118.903 -108.80 +146.16 +230.35 -211.95 -59.209
Table 4.4: Pairwise difference p−values for maximum applied force. Bolded
values are statistically significant at p < 0.05.
WT N348A N348W N348K vR111A N348A/Y211A vR111A/Y211A Y211D Y211T Y211A
N348A 0.60
N348W 0.31 0.077
N348K 0.20 0.038 0.81
vR111A 0.51 0.16 0.79 0.60
N348A/Y211A 0.29 0.07 0.95 0.81 0.77
vR111A/Y211A 0.82 0.79 0.21 0.13 0.35 0.20
Y211D 0.00093 0.0012 1.4x10−5 5.0x10−6 5.6x10−5 1.2x10−5 0.0022
Y211T 0.01 0.018 0.00022 8.7x10−5 0.0008 0.0002 0.021 0.56
Y211A 0.0034 7.2x10−05 0.074 0.13 0.035 0.079 0.0016 4.2x10−10 4.2x10−8
N348W/Y211A 3.9x10−7 1.1x10−10 6.5x10−5 0.00021 1.6x10−5 7.2x10−5 1.3x10−7 ¡ 2x10−16 2.0x10−14 0.036
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Table 4.5: Pairwise difference p−values for interpolated AUC. Bolded values
are statistically significant at p < 0.05.
WT N348A N348W N348K vR111A N348A/Y211A vR111A/Y211A Y211D Y211T Y211A
N348A 0.33
N348W 0.76 0.59
N348K 0.59 0.80 0.76
vR111A 0.55 0.85 0.76 0.94
N348A/Y211A 0.017 0.07 0.031 0.076 0.08
vR111A/Y211A 0.26 0.76 0.46 0.68 0.72 0.22
Y211D 0.33 0.029 0.18 0.09 0.08 0.00046 0.029
Y211T 0.09 0.0056 0.046 0.027 0.023 4.1x10−5 0.006 0.59
Y211A 0.0056 0.027 0.016 0.029 0.031 0.75 0.09 8.2x10−5 8.5x10−6
N348W/Y211A 0.006 0.029 0.017 0.032 0.034 0.76 0.1 9.4x10−5 8.5x10−6 0.94
4.3.3 Comparative analysis of the GP1/hTfR1 interface
Considering the involvement of extended hydrogen-bonding networks in
the GP1/hTfR1 interface (Figure 4.2), it was not clear that individual alanine
mutations, even those that should destroy such networks, would significantly
change the strength of interaction. One major advantage of first principles sim-
ulations is the ability to test mutations other than alanine without additional
underlying assumptions in the energy function. As shown in Table 4.1, we
made additional mutations based on biochemical intuition or available exper-
imental data to chemically diverse amino acids including tryptophan, lysine,
aspartate, and threonine. Several mutations caused significant relative affinity
changes. In addition, to detect synergistic effects, we tested several double
mutants where both mutations appeared to cause similar changes in binding.
Then, we compared the size of those differences to single mutants (Figure 4.9
and 4.8).
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Figure 4.8: Distribution of interpolated maximum force for all bound com-
plexes tested. Stars above the boxplots indicate a statistically significant dif-
ference in mean maximum force relative to the WT complex.
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Figure 4.9: Distribution of interpolated maximum force for three different
GP1/hTfR1 complexes. The WT GP1-hTfR1 complex in the middle is flanked
by the tighter binding mutant Y211D on the right and the weaker binding
double mutant N348W/Y211A on the left. The large non-overlapping areas
indicate a large and statistically significant difference in these three complexes.
Although Y211A appears to have a large impact on binding affinity,
no single mutant can provide enough evidence to understand the biochemical
difference in binding mechanism. Since alanine is both smaller than tyrosine
and also incapable of participating in hydrogen-bond interactions, we tested
further mutations to identify the critical biochemical difference responsible for
change in binding affinity. In particular, we substituted smaller side chains
that, like tyrosine, were capable of hydrogen bonding. We chose Y211D and
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Y211T, two mutations that have been discussed in the context of selection
pressure on hosts in rodent populations [19, 78, 79]. Both mutations proved
capable of causing a significant change in binding affinity in our simulations,
but the change appeared to be increased affinity (Figures 4.9 and 4.8, and
Table 4.4).
We also simulated several point mutations at N348 in the hTfR1. As
discussed above, the alanine mutation at this site showed no significant dif-
ference in maximum applied force or AUC from WT (Tables 4.4 and 4.5).
In addition, neither the N348Lys nor the N348W mutation showed a signifi-
cant difference from WT. For both of these mutations, however, mean max-
imum applied force and mean AUC was lower than for WT (See Table 4.2).
On the other hand, there was a detectable difference between N348A and
N348Lys (Tables 4.4 and 4.5), with N348Lys being a weaker binder. Moreover,
N348W showed nearly identical results to N348Lys. The mutations to large
amino acids (N348W and N348Lys) produced nearly identical affinity changes,
whereas the mutations to amino acids not capable of hydrogen bonding (N348A
and N348W) produced significantly different affinity changes (Table 4.3). To
check the consistency of our results, we hypothesized that the combination of
Y211A and N348W, being chemically disconnected in two different hydrogen-
bonding networks, would lead to a synergistic loss-of-binding. As expected,
the double mutant was the weakest binding mutant tested (p < 10−6, Ta-
bles 4.4 and 4.5) in this study. Further, according to maximum applied force
(but not AUC), the combination of Y211A and N348W also showed signifi-
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cantly weaker binding than Y211A by itself (Tables 4.4 and 4.5). We suspect
that the effect of N348W alone is near the limit of detection using our method.
A larger number of replicates would possibly have resolved affinity differences
between N348W and WT or other mutants more consistently.
Last, we further analyzed a single mutation in GP1, vR111A. As men-
tioned previously, in our simulations this mutant showed no significant change
in either maximum applied force or AUC (Tables 4.4 and 4.5), even though
both quantities were, on average, lower than in WT (Table 4.2). This re-
sult was somewhat surprising, since Y211A, presumably disrupting the same
hydrogen-bonding network as vR111A, displayed a significant reduction in
affinity. To probe the interaction between position 111 in the GP1 and position
211 in the hTfR1 further, we also tested the double mutant vR111A/Y211A.
This double mutant showed affinity indistinguishable from WT and signifi-
cantly higher than Y211A alone (Table 4.3). This result shows that the two
sites do indeed interact, and that replacing the hydrogen-bonding network at
these sites with a hydrophobic interaction could lead to comparable binding
affinity.
4.4 Discussion
We have applied a method utilizing steering forces in all-atom molecular
dynamics simulations to evaluate the effects of mutations at the GP1/hTfR1
interface. We modeled mutations at several sites in the GP1/hTfR1 inter-
face, and verified that our computational protocol was sensitive enough to
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distinguish point mutants in hTfR1. Further, we identified two test statistics,
maximum applied force and AUC, that can be used as proxies for binding
affinity. Both of these statistics correlate well with FEP, but offer the simplic-
ity of not requiring a large commitment to planning for the theoretical issues
inherent to free energy methods. We systematically tested several point muta-
tions to understand their contribution to the binding interaction. In the case
of N348Lys, we have shown that the static structure provides little insight into
why this mutation causes loss-of-infectivity in vivo. While N348 appears to
be involved in a hydrogen-bonding network in the static structure, change in
binding at that site may actually be caused by size and charge restriction. We
also found that a negatively polar residue at site 211 in hTfR1 seem critical
for a tight binding interaction. Any non-polar mutation at Y211 in hTfR1 is
likely to completely halt viral entry and dramatically decrease the chances of
MACV infection.
Traditionally SMD has been either applied to compute equilibrium free
energies via a non-equilibrium approximation [33, 72, 73], used to estimate
protein stability through unfolding [60], or used to calculate the absolute free
energy of small molecule ligand binding [26]. Likewise, others have used SMD
to understand the process of binding and unbinding at a resolution unmatched
by experiment [23, 33]. Here, we have shown that SMD can provide insight
into the relative strength of protein–protein interactions. Via SMD, one can
separate mutations whose likely effect is altered binding affinity with simple
statistics like maximum force of separation. Thus, SMD may open avenues
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for subsequent experimental work in some situations where FEP may be pro-
hibitively difficult.
Our findings rationalize several effects observed in both infectivity data
and rodent populations [19,78]. First, we found that some substitutions at po-
sitions 211 and 348 did affect the strength of receptor binding. However, the
computational data suggest that the reason and nature of the effects at these
two sites are very different. At position 211, mutations to non-polar residues
cause a large change in binding. This is congruent with what is known from
viral entry data [19, 78]. By contrast, mutations at position 348 need only
be small to maintain WT binding. The ability to hydrogen bond appears to
be insignificant. This can be inferred from the fact that Y211A paired with
large (W) and positively charged (Lys) substitutions at position 348 results
in a larger than expected synergistic difference. That is, the double mutant
Y211A/N348W caused a much larger decrease in binding than we expected
from either mutation individually. Third, the GP1 mutation vR111A causes
a loss-of-infection during in vitro infectivity assays [79], yet it was indistin-
guishable from the WT complex in our simulations. Although Y211A was
the most disruptive single mutant we tested, vR111A in the GP1 was able to
restore mean maximum applied force to WT levels (Table 4.2), and to levels
significantly higher than observed for Y211A alone.
We would like to emphasize here that we cannot expect perfect agree-
ment between our simulations and the available experimental data, but the
correspondence to a well established free energy method bolsters our con-
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clusions. While we have shown that our method can distinguish individual
point mutations, we do not know the limit of detection with our method.
First, it is possible that some mutants display measurable phenotypic effects
in experiments yet appear identical in simulation. More extensive sampling
or refinement of the simulation protocol could help to differentiate such mu-
tants (see also next paragraph). Second, the SMD method is fundamentally
limited by the accuracy of our starting structure. Third, the available exper-
imental data for the GP1/hTfR1 system were generally obtained from entry
assays or whole-cell binding assays rather than molecular binding assays. A
mutant may cause a phenotypic difference in infectivity without generating a
signal by our method. For example, entry could be lost in the experimental
system because the protein is grossly or partially misfolded. An additional
analytical step with circular dichroism or an analogous technique could clarify
such large-scale folding differences. Further, since our simulations start with a
bound structure, any changes that may dramatically affect the rate of associ-
ation (different folds, trafficking issues, etc.) or relative orientation of the two
proteins would be underestimated by our method.
There are a few additional challenges for investigating host-virus inter-
actions via molecular dynamics simulation. As with any atomistic simulation,
there is going to be a fairly large noise-to-signal ratio. To reduce noise, one
could further customize each simulation, e.g. by determining the optimal
pulling speed. Furthermore, larger amounts of computational resources will
have a direct and powerful impact on the strength of any atomistic study [48].
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Such resources could come in the form of increased compute time, improved
code, or customized hardware for floating point operations [88]. With im-
proved resources, we could investigate thousands of individual permutations
in the GP1/hTfR1 binding interface. In addition, with additional compute
time it would be possible to incorporate equilibrium sampling approaches [13]
or use brute force equilibrium approaches [32] to improve resolution.
For future studies, although our approach offers the simplicity of not
requiring prior knowledge about a system of interest (other than a bound
model), at this point SMD may not the best approach for many relative affin-
ity calculations. To ensure one’s results are independent of the dissociation
path one selects would require computing the work of separation for all likely
paths. Such an approach eventually requires using the Jarzynski inequality [47]
to establish a lower limit for binding energy and would quickly become com-
putationally inefficient for evaluating a large number of mutations in most
systems. However, considering the strong correlation between FEP and SMD
in this system, it may not be important to ensure one’s results are path inde-
pendent for relative affinity calculations, as long as the same path is used for
all complexes.
More importantly, with no a priori knowledge of the appropriate num-
ber of equilibration samples, the best duration of equilibration, the appropriate
number of pulling runs, or the best pulling speed means the computational ex-
pense in our SMD protocol may not be commensurate with the information
provided. For example, another all atom approach that makes calculations
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via short simulations of spatially restrained complexes has proven capable of
generating relatively accurate binding affinities with less compute time than is
required from our steering strategy [39,40]. That being said, there is no reason
to believe this SMD approach to mutagenic studies could not be optimized to
reduce computational expense. Further analysis will be needed to understand
the lower limits of resources required for accurate predictions.
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Chapter 5
Conclusion
5.1 Discussion
There are a number of important points to come from this work. First,
it is not only possible to incorporate measures of protein structure into models
of molecular evolution, it can be a relatively simple task. Moreover, by incor-
porating relative solvent accessibility into the Goldman-Yang model, we can
account for 5-10% more of the variation in the data compared to structure-
naive models. We saw an improved fit via AIC and we were able to identify
sites that were more conserved than we would have expected based on the
site’s RSA. In addition, our RSA-based method was able to identify several
sites in hemagglutinin that are near the sialic acid binding region that evolve
much faster than their RSA would have predicted.
Second, we applied our method to compare the evolutionary rate vari-
ation in hemagglutinin in different host species. We found that despite small
numbers of sequences, random effect likelihood models tend to correctly reca-
pitulate evolutionary rates even when fixed effect likelihood models perform
poorly. In addition, we found that homologous sites in different host species
had similar, though not identical, evolutionary rates. By making a direct
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site-for-site comparison between two different host species, we were able to
quantify the extent to which having a similar overall structure could account
for the evolutionary rate variation among sites in the same protein. It appears
structure could account for up to 24% to 36% of the evolutionary rate varia-
tion in hemagglutinin. Moreover, this number is probably near the lower limit
for the extent to which structure constrains the evolutionary rate of proteins.
Since hemagglutinin has a very strong adaptive pressure from one season to
the next, purifying selection for biophysical stability is probably more relaxed
than it is in most mammalian genes.
Third, to interrogate the effects of substitutions similar to those in
the previous two chapters, we applied steered molecular dynamics simulations
to pull apart a protein–protein complex. We found that with 50 replicates
or less, we could differentiate 4 out of 10 mutants from the WT complex.
Furthermore, we were able to see differences in these complexes by applying a
force in only one direction and using the simple metric of maximum applied
force. We were able to show that those differences make sense in light of some
existing experimental data from viral entry assays. And finally, our results
were in good agreement with one well established technique for calculating
the relative free energy differences among various related structures.
5.2 Future Work
Next, we plan to extend our previous work to simulating full evolu-
tionary trajectories. We will use a protein–protein interaction model system
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that is similar to that of chapter 4. We want to understand the extent to
which host tropism constraints affect the evolutionary process of viral binding
proteins. We will simulate the evolution of the viral protein while leaving mul-
tiple potential host receptors static. In each test case, we will mutate amino
acids in the protein–protein complex and use SMD or some other method to
analyze the energy of interaction and internal stability. Then, we will use the
metropolis criterion to either accept or reject the test mutation. The fitness
landscape will be defined by a sigmoidal function where any mutation that
improves binding will be accepted; any mutation that reduces binding below
some threshold will have an exponentially declining probability of acceptance.
With multiple possible homologous host receptors, we can multiply the proba-
bilities of binding to the receptors to arrive at a final probability of acceptance
per mutation tested. We expect that enforcing binding to three different host
receptors will slow the adaptive changes that allow switching from one host to
another. Likewise, relaxing the contraint of binding to a competent host will
free the virus to adapt quickly to a new host. In addition, as the mutational
process will be carried out in DNA, we can calculate the evolutionary rate as in
chapters 2 and 3. We expect to see the evolutionary rate in the protein–protein
interface will be even more constrained than residues with similar RSA in the
core of the protein. Moreover, we expect that increasing the number of binding
partners will more negatively constrain the evolutionary rate of interface sites.
We hope simulations in a controlled evolutionary environment will inform our
initial evolutionary rate studies; furthermore, they allow us to determine the
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extent to which we should expect purifying selection on biophysical stability
to depress to rate of adaptive evolution in viral proteins.
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